id	sid	tid	token	lemma	pos
bam-14272	1	1	european	european	PROPN
bam-14272	1	2	journal	journal	PROPN
bam-14272	1	3	of	of	ADP
bam-14272	1	4	translational	translational	ADJ
bam-14272	1	5	myology	myology	NOUN
bam-14272	1	6	pissn	pissn	NOUN
bam-14272	1	7	:	:	PUNCT
bam-14272	1	8	2037	2037	NUM
bam-14272	1	9	-	-	SYM
bam-14272	1	10	7452	7452	NUM
bam-14272	1	11	eissn	eissn	NOUN
bam-14272	1	12	:	:	PUNCT
bam-14272	1	13	2037	2037	NUM
bam-14272	1	14	-	-	SYM
bam-14272	1	15	7460	7460	NUM
bam-14272	1	16	https://www.pagepressjournals.org/index.php/bam/index	https://www.pagepressjournals.org/index.php/bam/index	NOUN
bam-14272	1	17	publisher	publisher	NOUN
bam-14272	1	18	's	's	PART
bam-14272	1	19	disclaimer	disclaimer	NOUN
bam-14272	1	20	.	.	PUNCT
bam-14272	2	1	e	e	X
bam-14272	2	2	-	-	NOUN
bam-14272	2	3	publishing	publishing	NOUN
bam-14272	2	4	ahead	ahead	ADV
bam-14272	2	5	of	of	ADP
bam-14272	2	6	print	print	NOUN
bam-14272	2	7	is	be	AUX
bam-14272	2	8	increasingly	increasingly	ADV
bam-14272	2	9	important	important	ADJ
bam-14272	2	10	for	for	ADP
bam-14272	2	11	the	the	DET
bam-14272	2	12	rapid	rapid	ADJ
bam-14272	2	13	dissemination	dissemination	NOUN
bam-14272	2	14	of	of	ADP
bam-14272	2	15	science	science	NOUN
bam-14272	2	16	.	.	PUNCT
bam-14272	3	1	the	the	DET
bam-14272	3	2	early	early	ADJ
bam-14272	3	3	access	access	NOUN
bam-14272	3	4	service	service	NOUN
bam-14272	3	5	lets	let	VERB
bam-14272	3	6	users	user	NOUN
bam-14272	3	7	access	access	VERB
bam-14272	3	8	peer	peer	NOUN
bam-14272	3	9	-	-	PUNCT
bam-14272	3	10	reviewed	review	VERB
bam-14272	3	11	articles	article	NOUN
bam-14272	3	12	well	well	ADV
bam-14272	3	13	before	before	ADP
bam-14272	3	14	print	print	NOUN
bam-14272	3	15	/	/	SYM
bam-14272	3	16	regular	regular	ADJ
bam-14272	3	17	issue	issue	NOUN
bam-14272	3	18	publication	publication	NOUN
bam-14272	3	19	,	,	PUNCT
bam-14272	3	20	significantly	significantly	ADV
bam-14272	3	21	reducing	reduce	VERB
bam-14272	3	22	the	the	DET
bam-14272	3	23	time	time	NOUN
bam-14272	3	24	it	it	PRON
bam-14272	3	25	takes	take	VERB
bam-14272	3	26	for	for	ADP
bam-14272	3	27	critical	critical	ADJ
bam-14272	3	28	findings	finding	NOUN
bam-14272	3	29	to	to	PART
bam-14272	3	30	reach	reach	VERB
bam-14272	3	31	the	the	DET
bam-14272	3	32	research	research	NOUN
bam-14272	3	33	community	community	NOUN
bam-14272	3	34	.	.	PUNCT
bam-14272	4	1	these	these	DET
bam-14272	4	2	articles	article	NOUN
bam-14272	4	3	are	be	AUX
bam-14272	4	4	searchable	searchable	ADJ
bam-14272	4	5	and	and	CCONJ
bam-14272	4	6	citable	citable	ADJ
bam-14272	4	7	by	by	ADP
bam-14272	4	8	their	their	PRON
bam-14272	4	9	doi	doi	NOUN
bam-14272	4	10	(	(	PUNCT
bam-14272	4	11	digital	digital	ADJ
bam-14272	4	12	object	object	NOUN
bam-14272	4	13	identifier	identifier	NOUN
bam-14272	4	14	)	)	PUNCT
bam-14272	4	15	.	.	PUNCT
bam-14272	5	1	the	the	DET
bam-14272	5	2	european	european	PROPN
bam-14272	5	3	journal	journal	PROPN
bam-14272	5	4	of	of	ADP
bam-14272	5	5	translational	translational	ADJ
bam-14272	5	6	myology	myology	NOUN
bam-14272	5	7	is	be	AUX
bam-14272	5	8	,	,	PUNCT
bam-14272	5	9	therefore	therefore	ADV
bam-14272	5	10	,	,	PUNCT
bam-14272	5	11	e	e	X
bam-14272	5	12	-	-	ADJ
bam-14272	5	13	publishing	publish	VERB
bam-14272	5	14	pdf	pdf	NOUN
bam-14272	5	15	files	file	NOUN
bam-14272	5	16	of	of	ADP
bam-14272	5	17	an	an	DET
bam-14272	5	18	early	early	ADJ
bam-14272	5	19	version	version	NOUN
bam-14272	5	20	of	of	ADP
bam-14272	5	21	manuscripts	manuscript	NOUN
bam-14272	5	22	that	that	PRON
bam-14272	5	23	undergone	undergo	VERB
bam-14272	5	24	a	a	DET
bam-14272	5	25	regular	regular	ADJ
bam-14272	5	26	peer	peer	NOUN
bam-14272	5	27	review	review	NOUN
bam-14272	5	28	and	and	CCONJ
bam-14272	5	29	have	have	AUX
bam-14272	5	30	been	be	AUX
bam-14272	5	31	accepted	accept	VERB
bam-14272	5	32	for	for	ADP
bam-14272	5	33	publication	publication	NOUN
bam-14272	5	34	,	,	PUNCT
bam-14272	5	35	but	but	CCONJ
bam-14272	5	36	have	have	AUX
bam-14272	5	37	not	not	PART
bam-14272	5	38	been	be	AUX
bam-14272	5	39	through	through	ADP
bam-14272	5	40	the	the	DET
bam-14272	5	41	typesetting	typesetting	NOUN
bam-14272	5	42	,	,	PUNCT
bam-14272	5	43	pagination	pagination	NOUN
bam-14272	5	44	and	and	CCONJ
bam-14272	5	45	proofreading	proofreading	NOUN
bam-14272	5	46	processes	process	NOUN
bam-14272	5	47	,	,	PUNCT
bam-14272	5	48	which	which	PRON
bam-14272	5	49	may	may	AUX
bam-14272	5	50	lead	lead	VERB
bam-14272	5	51	to	to	ADP
bam-14272	5	52	differences	difference	NOUN
bam-14272	5	53	between	between	ADP
bam-14272	5	54	this	this	DET
bam-14272	5	55	version	version	NOUN
bam-14272	5	56	and	and	CCONJ
bam-14272	5	57	the	the	DET
bam-14272	5	58	final	final	ADJ
bam-14272	5	59	one	one	NUM
bam-14272	5	60	.	.	PUNCT
bam-14272	6	1	the	the	DET
bam-14272	6	2	final	final	ADJ
bam-14272	6	3	version	version	NOUN
bam-14272	6	4	of	of	ADP
bam-14272	6	5	the	the	DET
bam-14272	6	6	manuscript	manuscript	NOUN
bam-14272	6	7	will	will	AUX
bam-14272	6	8	then	then	ADV
bam-14272	6	9	appear	appear	VERB
bam-14272	6	10	on	on	ADP
bam-14272	6	11	a	a	DET
bam-14272	6	12	regular	regular	ADJ
bam-14272	6	13	issue	issue	NOUN
bam-14272	6	14	of	of	ADP
bam-14272	6	15	the	the	DET
bam-14272	6	16	journal	journal	NOUN
bam-14272	6	17	.	.	PUNCT
bam-14272	7	1	e	e	X
bam-14272	7	2	-	-	NOUN
bam-14272	7	3	publishing	publishing	NOUN
bam-14272	7	4	of	of	ADP
bam-14272	7	5	this	this	DET
bam-14272	7	6	pdf	pdf	NOUN
bam-14272	7	7	file	file	NOUN
bam-14272	7	8	has	have	AUX
bam-14272	7	9	been	be	AUX
bam-14272	7	10	approved	approve	VERB
bam-14272	7	11	by	by	ADP
bam-14272	7	12	the	the	DET
bam-14272	7	13	authors	author	NOUN
bam-14272	7	14	.	.	PUNCT
bam-14272	8	1	eur	eur	PROPN
bam-14272	8	2	j	j	PROPN
bam-14272	8	3	transl	transl	PROPN
bam-14272	8	4	myol	myol	NOUN
bam-14272	8	5	2025	2025	NUM
bam-14272	8	6	[	[	X
bam-14272	8	7	online	online	ADV
bam-14272	8	8	ahead	ahead	ADV
bam-14272	8	9	of	of	ADP
bam-14272	8	10	print	print	NOUN
bam-14272	8	11	]	]	PUNCT
bam-14272	8	12	to	to	PART
bam-14272	8	13	cite	cite	VERB
bam-14272	8	14	this	this	DET
bam-14272	8	15	article	article	NOUN
bam-14272	8	16	:	:	PUNCT
bam-14272	8	17	lei	lei	PROPN
bam-14272	8	18	w	w	PROPN
bam-14272	8	19	,	,	PUNCT
bam-14272	8	20	min	min	PROPN
bam-14272	8	21	h	h	PROPN
bam-14272	8	22	,	,	PUNCT
bam-14272	8	23	yue	yue	PROPN
bam-14272	8	24	c	c	PROPN
bam-14272	8	25	,	,	PUNCT
bam-14272	8	26	et	et	PROPN
bam-14272	8	27	al	al	PROPN
bam-14272	8	28	.	.	PUNCT
bam-14272	8	29	analysis	analysis	NOUN
bam-14272	8	30	of	of	ADP
bam-14272	8	31	the	the	DET
bam-14272	8	32	effects	effect	NOUN
bam-14272	8	33	of	of	ADP
bam-14272	8	34	dapagliflozin	dapagliflozin	NOUN
bam-14272	8	35	on	on	ADP
bam-14272	8	36	cardiac	cardiac	ADJ
bam-14272	8	37	myocyte	myocyte	PROPN
bam-14272	8	38	injury	injury	NOUN
bam-14272	8	39	markers	marker	NOUN
bam-14272	8	40	and	and	CCONJ
bam-14272	8	41	left	leave	VERB
bam-14272	8	42	ventricular	ventricular	ADJ
bam-14272	8	43	diastolic	diastolic	ADJ
bam-14272	8	44	function	function	NOUN
bam-14272	8	45	in	in	ADP
bam-14272	8	46	heart	heart	NOUN
bam-14272	8	47	failure	failure	NOUN
bam-14272	8	48	patients	patient	NOUN
bam-14272	8	49	with	with	ADP
bam-14272	8	50	preserved	preserve	VERB
bam-14272	8	51	ejection	ejection	NOUN
bam-14272	8	52	fraction	fraction	NOUN
bam-14272	8	53	after	after	ADP
bam-14272	8	54	percutaneous	percutaneous	ADJ
bam-14272	8	55	coronary	coronary	ADJ
bam-14272	8	56	intervention	intervention	NOUN
bam-14272	8	57	.	.	PUNCT
bam-14272	9	1	eur	eur	PROPN
bam-14272	9	2	j	j	PROPN
bam-14272	9	3	transl	transl	PROPN
bam-14272	9	4	myol	myol	PROPN
bam-14272	9	5	doi	doi	PROPN
bam-14272	9	6	:	:	PUNCT
bam-14272	9	7	10.4081	10.4081	NUM
bam-14272	9	8	/	/	SYM
bam-14272	9	9	ejtm.2025.14272	ejtm.2025.14272	VERB
bam-14272	9	10	©	©	PROPN
bam-14272	9	11	the	the	DET
bam-14272	9	12	author(s	author(s	PROPN
bam-14272	9	13	)	)	PUNCT
bam-14272	9	14	,	,	PUNCT
bam-14272	9	15	2025	2025	NUM
bam-14272	9	16	licensee	licensee	NOUN
bam-14272	9	17	pagepress	pagepress	NOUN
bam-14272	9	18	,	,	PUNCT
bam-14272	9	19	italy	italy	PROPN
bam-14272	9	20	note	note	VERB
bam-14272	9	21	:	:	PUNCT
bam-14272	9	22	the	the	DET
bam-14272	9	23	publisher	publisher	NOUN
bam-14272	9	24	is	be	AUX
bam-14272	9	25	not	not	PART
bam-14272	9	26	responsible	responsible	ADJ
bam-14272	9	27	for	for	ADP
bam-14272	9	28	the	the	DET
bam-14272	9	29	content	content	NOUN
bam-14272	9	30	or	or	CCONJ
bam-14272	9	31	functionality	functionality	NOUN
bam-14272	9	32	of	of	ADP
bam-14272	9	33	any	any	DET
bam-14272	9	34	supporting	support	VERB
bam-14272	9	35	information	information	NOUN
bam-14272	9	36	supplied	supply	VERB
bam-14272	9	37	by	by	ADP
bam-14272	9	38	the	the	DET
bam-14272	9	39	authors	author	NOUN
bam-14272	9	40	.	.	PUNCT
bam-14272	10	1	any	any	DET
bam-14272	10	2	queries	query	NOUN
bam-14272	10	3	should	should	AUX
bam-14272	10	4	be	be	AUX
bam-14272	10	5	directed	direct	VERB
bam-14272	10	6	to	to	ADP
bam-14272	10	7	the	the	DET
bam-14272	10	8	corresponding	corresponding	ADJ
bam-14272	10	9	author	author	NOUN
bam-14272	10	10	for	for	ADP
bam-14272	10	11	the	the	DET
bam-14272	10	12	article	article	NOUN
bam-14272	10	13	.	.	PUNCT
bam-14272	11	1	all	all	DET
bam-14272	11	2	claims	claim	NOUN
bam-14272	11	3	expressed	express	VERB
bam-14272	11	4	in	in	ADP
bam-14272	11	5	this	this	DET
bam-14272	11	6	article	article	NOUN
bam-14272	11	7	are	be	AUX
bam-14272	11	8	solely	solely	ADV
bam-14272	11	9	those	those	PRON
bam-14272	11	10	of	of	ADP
bam-14272	11	11	the	the	DET
bam-14272	11	12	authors	author	NOUN
bam-14272	11	13	and	and	CCONJ
bam-14272	11	14	do	do	AUX
bam-14272	11	15	not	not	PART
bam-14272	11	16	necessarily	necessarily	ADV
bam-14272	11	17	represent	represent	VERB
bam-14272	11	18	those	those	PRON
bam-14272	11	19	of	of	ADP
bam-14272	11	20	their	their	PRON
bam-14272	11	21	affiliated	affiliated	ADJ
bam-14272	11	22	organizations	organization	NOUN
bam-14272	11	23	,	,	PUNCT
bam-14272	11	24	or	or	CCONJ
bam-14272	11	25	those	those	PRON
bam-14272	11	26	of	of	ADP
bam-14272	11	27	the	the	DET
bam-14272	11	28	publisher	publisher	NOUN
bam-14272	11	29	,	,	PUNCT
bam-14272	11	30	the	the	DET
bam-14272	11	31	editors	editor	NOUN
bam-14272	11	32	and	and	CCONJ
bam-14272	11	33	the	the	DET
bam-14272	11	34	reviewers	reviewer	NOUN
bam-14272	11	35	.	.	PUNCT
bam-14272	12	1	any	any	DET
bam-14272	12	2	product	product	NOUN
bam-14272	12	3	that	that	PRON
bam-14272	12	4	may	may	AUX
bam-14272	12	5	be	be	AUX
bam-14272	12	6	evaluated	evaluate	VERB
bam-14272	12	7	in	in	ADP
bam-14272	12	8	this	this	DET
bam-14272	12	9	article	article	NOUN
bam-14272	12	10	or	or	CCONJ
bam-14272	12	11	claim	claim	NOUN
bam-14272	12	12	that	that	PRON
bam-14272	12	13	may	may	AUX
bam-14272	12	14	be	be	AUX
bam-14272	12	15	made	make	VERB
bam-14272	12	16	by	by	ADP
bam-14272	12	17	its	its	PRON
bam-14272	12	18	manufacturer	manufacturer	NOUN
bam-14272	12	19	is	be	AUX
bam-14272	12	20	not	not	PART
bam-14272	12	21	guaranteed	guarantee	VERB
bam-14272	12	22	or	or	CCONJ
bam-14272	12	23	endorsed	endorse	VERB
bam-14272	12	24	by	by	ADP
bam-14272	12	25	the	the	DET
bam-14272	12	26	publisher	publisher	NOUN
bam-14272	12	27	.	.	PUNCT
bam-14272	13	1	submitted	submit	VERB
bam-14272	13	2	:	:	PUNCT
bam-14272	13	3	22	22	NUM
bam-14272	13	4	august	august	PROPN
bam-14272	13	5	2025	2025	NUM
bam-14272	13	6	accepted	accept	VERB
bam-14272	13	7	:	:	PUNCT
bam-14272	13	8	7	7	NUM
bam-14272	13	9	september	september	PROPN
bam-14272	13	10	2025	2025	NUM
bam-14272	13	11	early	early	ADJ
bam-14272	13	12	access	access	NOUN
bam-14272	13	13	:	:	PUNCT
bam-14272	13	14	4	4	NUM
bam-14272	13	15	december	december	NOUN
bam-14272	13	16	2025	2025	NUM
bam-14272	13	17	https://www.pagepressjournals.org/index.php/bam/index	https://www.pagepressjournals.org/index.php/bam/index	NOUN
bam-14272	13	18	https://www.pagepress.org/site	https://www.pagepress.org/site	PART
bam-14272	13	19	analysis	analysis	NOUN
bam-14272	13	20	of	of	ADP
bam-14272	13	21	the	the	DET
bam-14272	13	22	effects	effect	NOUN
bam-14272	13	23	of	of	ADP
bam-14272	13	24	dapagliflozin	dapagliflozin	NOUN
bam-14272	13	25	on	on	ADP
bam-14272	13	26	cardiac	cardiac	ADJ
bam-14272	13	27	myocyte	myocyte	PROPN
bam-14272	13	28	injury	injury	NOUN
bam-14272	13	29	markers	marker	NOUN
bam-14272	13	30	and	and	CCONJ
bam-14272	13	31	left	leave	VERB
bam-14272	13	32	ventricular	ventricular	ADJ
bam-14272	13	33	diastolic	diastolic	ADJ
bam-14272	13	34	function	function	NOUN
bam-14272	13	35	in	in	ADP
bam-14272	13	36	heart	heart	NOUN
bam-14272	13	37	failure	failure	NOUN
bam-14272	13	38	patients	patient	NOUN
bam-14272	13	39	with	with	ADP
bam-14272	13	40	preserved	preserve	VERB
bam-14272	13	41	ejection	ejection	NOUN
bam-14272	13	42	fraction	fraction	NOUN
bam-14272	13	43	after	after	ADP
bam-14272	13	44	percutaneous	percutaneous	ADJ
bam-14272	13	45	coronary	coronary	ADJ
bam-14272	13	46	intervention	intervention	NOUN
bam-14272	13	47	wang	wang	PROPN
bam-14272	13	48	lei,1	lei,1	PROPN
bam-14272	13	49	hu	hu	PROPN
bam-14272	13	50	min,2	min,2	PROPN
bam-14272	13	51	chen	chen	PROPN
bam-14272	13	52	yue,2	yue,2	PROPN
bam-14272	13	53	zhang	zhang	PROPN
bam-14272	14	1	gejun,2	gejun,2	PROPN
bam-14272	14	2	wei	wei	PROPN
bam-14272	14	3	chao,2	chao,2	VERB
bam-14272	14	4	liu	liu	PROPN
bam-14272	14	5	qian3	qian3	PROPN
bam-14272	14	6	1cardiovascular	1cardiovascular	NUM
bam-14272	14	7	medicine	medicine	NOUN
bam-14272	14	8	,	,	PUNCT
bam-14272	14	9	the	the	DET
bam-14272	14	10	second	second	ADJ
bam-14272	14	11	affiliated	affiliated	ADJ
bam-14272	14	12	hospital	hospital	NOUN
bam-14272	14	13	of	of	ADP
bam-14272	14	14	wannan	wannan	PROPN
bam-14272	14	15	medical	medical	ADJ
bam-14272	14	16	college	college	NOUN
bam-14272	14	17	,	,	PUNCT
bam-14272	14	18	jinghu	jinghu	NOUN
bam-14272	14	19	district	district	NOUN
bam-14272	14	20	,	,	PUNCT
bam-14272	14	21	wuhu	wuhu	PROPN
bam-14272	14	22	city	city	PROPN
bam-14272	14	23	,	,	PUNCT
bam-14272	14	24	anhui	anhui	PROPN
bam-14272	14	25	province	province	PROPN
bam-14272	14	26	,	,	PUNCT
bam-14272	14	27	china	china	PROPN
bam-14272	14	28	;	;	PUNCT
bam-14272	14	29	2cardiothoracic	2cardiothoracic	NUM
bam-14272	14	30	and	and	CCONJ
bam-14272	14	31	vascular	vascular	ADJ
bam-14272	14	32	surgery	surgery	NOUN
bam-14272	14	33	,	,	PUNCT
bam-14272	14	34	the	the	DET
bam-14272	14	35	second	second	ADJ
bam-14272	14	36	affiliated	affiliated	ADJ
bam-14272	14	37	hospital	hospital	NOUN
bam-14272	14	38	of	of	ADP
bam-14272	14	39	wannan	wannan	PROPN
bam-14272	14	40	medical	medical	ADJ
bam-14272	14	41	college	college	NOUN
bam-14272	14	42	,	,	PUNCT
bam-14272	14	43	jinghu	jinghu	NOUN
bam-14272	14	44	district	district	NOUN
bam-14272	14	45	,	,	PUNCT
bam-14272	14	46	wuhu	wuhu	PROPN
bam-14272	14	47	city	city	PROPN
bam-14272	14	48	,	,	PUNCT
bam-14272	14	49	china	china	PROPN
bam-14272	14	50	;	;	PUNCT
bam-14272	14	51	3shanghai	3shanghai	NUM
bam-14272	14	52	zhongqiao	zhongqiao	NOUN
bam-14272	14	53	vocational	vocational	ADJ
bam-14272	14	54	and	and	CCONJ
bam-14272	14	55	technical	technical	PROPN
bam-14272	14	56	university	university	PROPN
bam-14272	14	57	,	,	PUNCT
bam-14272	14	58	shanghai	shanghai	PROPN
bam-14272	14	59	,	,	PUNCT
bam-14272	14	60	china	china	PROPN
bam-14272	14	61	abstract	abstract	PROPN
bam-14272	14	62	the	the	DET
bam-14272	14	63	objective	objective	NOUN
bam-14272	14	64	of	of	ADP
bam-14272	14	65	this	this	DET
bam-14272	14	66	study	study	NOUN
bam-14272	14	67	was	be	AUX
bam-14272	14	68	to	to	PART
bam-14272	14	69	analyze	analyze	VERB
bam-14272	14	70	the	the	DET
bam-14272	14	71	effects	effect	NOUN
bam-14272	14	72	of	of	ADP
bam-14272	14	73	dapagliflozin	dapagliflozin	NOUN
bam-14272	14	74	on	on	ADP
bam-14272	14	75	cardiac	cardiac	ADJ
bam-14272	14	76	myocyte	myocyte	PROPN
bam-14272	14	77	injury	injury	NOUN
bam-14272	14	78	markers	marker	NOUN
bam-14272	14	79	and	and	CCONJ
bam-14272	14	80	left	leave	VERB
bam-14272	14	81	ventricular	ventricular	ADJ
bam-14272	14	82	diastolic	diastolic	ADJ
bam-14272	14	83	function	function	NOUN
bam-14272	14	84	in	in	ADP
bam-14272	14	85	patients	patient	NOUN
bam-14272	14	86	with	with	ADP
bam-14272	14	87	heart	heart	NOUN
bam-14272	14	88	failure	failure	NOUN
bam-14272	14	89	with	with	ADP
bam-14272	14	90	preserved	preserve	VERB
bam-14272	14	91	ejection	ejection	NOUN
bam-14272	14	92	fraction	fraction	NOUN
bam-14272	14	93	(	(	PUNCT
bam-14272	14	94	hf	hf	NOUN
bam-14272	14	95	-	-	PUNCT
bam-14272	14	96	pef	pef	NOUN
bam-14272	14	97	)	)	PUNCT
bam-14272	14	98	after	after	ADP
bam-14272	14	99	percutaneous	percutaneous	ADJ
bam-14272	14	100	coronary	coronary	ADJ
bam-14272	14	101	intervention	intervention	NOUN
bam-14272	14	102	(	(	PUNCT
bam-14272	14	103	pci	pci	ADJ
bam-14272	14	104	)	)	PUNCT
bam-14272	14	105	.	.	PUNCT
bam-14272	15	1	the	the	DET
bam-14272	15	2	study	study	NOUN
bam-14272	15	3	included	include	VERB
bam-14272	15	4	120	120	NUM
bam-14272	15	5	hf	hf	ADJ
bam-14272	15	6	-	-	PUNCT
bam-14272	15	7	pef	pef	NOUN
bam-14272	15	8	patients	patient	NOUN
bam-14272	15	9	post	post	ADJ
bam-14272	15	10	-	-	ADJ
bam-14272	15	11	pci	pci	ADJ
bam-14272	15	12	treated	treat	VERB
bam-14272	15	13	at	at	ADP
bam-14272	15	14	our	our	PRON
bam-14272	15	15	hospital	hospital	NOUN
bam-14272	15	16	between	between	ADP
bam-14272	15	17	may	may	PROPN
bam-14272	15	18	2021	2021	NUM
bam-14272	15	19	and	and	CCONJ
bam-14272	15	20	may	may	PROPN
bam-14272	15	21	2024	2024	NUM
bam-14272	15	22	.	.	PUNCT
bam-14272	16	1	patients	patient	NOUN
bam-14272	16	2	were	be	AUX
bam-14272	16	3	divided	divide	VERB
bam-14272	16	4	into	into	ADP
bam-14272	16	5	two	two	NUM
bam-14272	16	6	groups	group	NOUN
bam-14272	16	7	:	:	PUNCT
bam-14272	16	8	conventional	conventional	ADJ
bam-14272	16	9	therapy	therapy	NOUN
bam-14272	16	10	(	(	PUNCT
bam-14272	16	11	n=49	n=49	NUM
bam-14272	16	12	)	)	PUNCT
bam-14272	16	13	and	and	CCONJ
bam-14272	16	14	dapagliflozin	dapagliflozin	PROPN
bam-14272	16	15	plus	plus	CCONJ
bam-14272	16	16	conventional	conventional	ADJ
bam-14272	16	17	therapy	therapy	NOUN
bam-14272	16	18	(	(	PUNCT
bam-14272	16	19	n=71	n=71	NOUN
bam-14272	16	20	)	)	PUNCT
bam-14272	16	21	.	.	PUNCT
bam-14272	17	1	serum	serum	VERB
bam-14272	17	2	cardiac	cardiac	ADJ
bam-14272	17	3	troponin	troponin	PROPN
bam-14272	18	1	i	i	PROPN
bam-14272	18	2	(	(	PUNCT
bam-14272	18	3	ctni	ctni	NOUN
bam-14272	18	4	)	)	PUNCT
bam-14272	18	5	and	and	CCONJ
bam-14272	18	6	serum	serum	VERB
bam-14272	18	7	amyloid	amyloid	PROPN
bam-14272	18	8	a	a	DET
bam-14272	18	9	(	(	PUNCT
bam-14272	18	10	saa	saa	PROPN
bam-14272	18	11	)	)	PUNCT
bam-14272	18	12	were	be	AUX
bam-14272	18	13	measured	measure	VERB
bam-14272	18	14	.	.	PUNCT
bam-14272	19	1	left	leave	VERB
bam-14272	19	2	ventricular	ventricular	ADJ
bam-14272	19	3	function	function	NOUN
bam-14272	19	4	was	be	AUX
bam-14272	19	5	assessed	assess	VERB
bam-14272	19	6	by	by	ADP
bam-14272	19	7	ejection	ejection	NOUN
bam-14272	19	8	fraction	fraction	NOUN
bam-14272	19	9	(	(	PUNCT
bam-14272	19	10	ef	ef	PROPN
bam-14272	19	11	)	)	PUNCT
bam-14272	19	12	and	and	CCONJ
bam-14272	19	13	the	the	DET
bam-14272	19	14	e	e	NOUN
bam-14272	19	15	/	/	SYM
bam-14272	19	16	e	e	NOUN
bam-14272	19	17	’	'	PUNCT
bam-14272	19	18	ratio	ratio	NOUN
bam-14272	19	19	.	.	PUNCT
bam-14272	20	1	the	the	DET
bam-14272	20	2	incidence	incidence	NOUN
bam-14272	20	3	of	of	ADP
bam-14272	20	4	major	major	ADJ
bam-14272	20	5	adverse	adverse	ADJ
bam-14272	20	6	cardiovascular	cardiovascular	ADJ
bam-14272	20	7	events	event	NOUN
bam-14272	20	8	(	(	PUNCT
bam-14272	20	9	mace	mace	NOUN
bam-14272	20	10	)	)	PUNCT
bam-14272	20	11	was	be	AUX
bam-14272	20	12	also	also	ADV
bam-14272	20	13	recorded	record	VERB
bam-14272	20	14	.	.	PUNCT
bam-14272	21	1	after	after	ADP
bam-14272	21	2	treatment	treatment	NOUN
bam-14272	21	3	,	,	PUNCT
bam-14272	21	4	the	the	DET
bam-14272	21	5	dapagliflozin	dapagliflozin	PROPN
bam-14272	21	6	group	group	PROPN
bam-14272	21	7	showed	show	VERB
bam-14272	21	8	significantly	significantly	ADV
bam-14272	21	9	lower	low	ADJ
bam-14272	21	10	ctni	ctni	NOUN
bam-14272	21	11	and	and	CCONJ
bam-14272	21	12	saa	saa	PROPN
bam-14272	21	13	levels	level	NOUN
bam-14272	21	14	compared	compare	VERB
bam-14272	21	15	to	to	ADP
bam-14272	21	16	the	the	DET
bam-14272	21	17	conventional	conventional	ADJ
bam-14272	21	18	group	group	NOUN
bam-14272	21	19	(	(	PUNCT
bam-14272	21	20	p<0.05	p<0.05	PROPN
bam-14272	21	21	)	)	PUNCT
bam-14272	21	22	.	.	PUNCT
bam-14272	22	1	ef	ef	PROPN
bam-14272	22	2	was	be	AUX
bam-14272	22	3	higher	high	ADJ
bam-14272	22	4	and	and	CCONJ
bam-14272	22	5	e	e	NOUN
bam-14272	22	6	/	/	SYM
bam-14272	22	7	e	e	NOUN
bam-14272	22	8	’	'	PUNCT
bam-14272	22	9	ratio	ratio	NOUN
bam-14272	22	10	was	be	AUX
bam-14272	22	11	lower	low	ADJ
bam-14272	22	12	in	in	ADP
bam-14272	22	13	the	the	DET
bam-14272	22	14	dapagliflozin	dapagliflozin	PROPN
bam-14272	22	15	group	group	NOUN
bam-14272	22	16	(	(	PUNCT
bam-14272	22	17	p<0.05	p<0.05	PROPN
bam-14272	22	18	)	)	PUNCT
bam-14272	22	19	.	.	PUNCT
bam-14272	23	1	the	the	DET
bam-14272	23	2	incidence	incidence	NOUN
bam-14272	23	3	of	of	ADP
bam-14272	23	4	mace	mace	NOUN
bam-14272	23	5	was	be	AUX
bam-14272	23	6	reduced	reduce	VERB
bam-14272	23	7	to	to	ADP
bam-14272	23	8	1.41	1.41	NUM
bam-14272	23	9	%	%	NOUN
bam-14272	23	10	versus	versus	ADP
bam-14272	23	11	12.24	12.24	NUM
bam-14272	23	12	%	%	NOUN
bam-14272	23	13	in	in	ADP
bam-14272	23	14	the	the	DET
bam-14272	23	15	conventional	conventional	ADJ
bam-14272	23	16	group	group	NOUN
bam-14272	23	17	(	(	PUNCT
bam-14272	23	18	p<0.05	p<0.05	NOUN
bam-14272	23	19	)	)	PUNCT
bam-14272	23	20	.	.	PUNCT
bam-14272	24	1	in	in	ADP
bam-14272	24	2	conclusion	conclusion	NOUN
bam-14272	24	3	,	,	PUNCT
bam-14272	24	4	dapagliflozin	dapagliflozin	PROPN
bam-14272	24	5	effectively	effectively	ADV
bam-14272	24	6	reduces	reduce	VERB
bam-14272	24	7	cardiac	cardiac	ADJ
bam-14272	24	8	myocyte	myocyte	NOUN
bam-14272	24	9	injury	injury	NOUN
bam-14272	24	10	markers	marker	NOUN
bam-14272	24	11	,	,	PUNCT
bam-14272	24	12	improves	improves	AUX
bam-14272	24	13	left	leave	VERB
bam-14272	24	14	ventricular	ventricular	ADJ
bam-14272	24	15	diastolic	diastolic	ADJ
bam-14272	24	16	function	function	NOUN
bam-14272	24	17	,	,	PUNCT
bam-14272	24	18	and	and	CCONJ
bam-14272	24	19	lowers	lower	VERB
bam-14272	24	20	the	the	DET
bam-14272	24	21	incidence	incidence	NOUN
bam-14272	24	22	of	of	ADP
bam-14272	24	23	mace	mace	NOUN
bam-14272	24	24	in	in	ADP
bam-14272	24	25	hf	hf	NOUN
bam-14272	24	26	-	-	PUNCT
bam-14272	24	27	pef	pef	NOUN
bam-14272	24	28	patients	patient	NOUN
bam-14272	24	29	after	after	ADP
bam-14272	24	30	pci	pci	ADJ
bam-14272	24	31	,	,	PUNCT
bam-14272	24	32	demonstrating	demonstrate	VERB
bam-14272	24	33	significant	significant	ADJ
bam-14272	24	34	translational	translational	ADJ
bam-14272	24	35	benefits	benefit	NOUN
bam-14272	24	36	for	for	ADP
bam-14272	24	37	cardiac	cardiac	ADJ
bam-14272	24	38	muscle	muscle	NOUN
bam-14272	24	39	function	function	NOUN
bam-14272	24	40	.	.	PUNCT
bam-14272	25	1	key	key	ADJ
bam-14272	25	2	words	word	NOUN
bam-14272	25	3	:	:	PUNCT
bam-14272	25	4	dapagliflozin	dapagliflozin	NOUN
bam-14272	25	5	;	;	PUNCT
bam-14272	25	6	cardiac	cardiac	ADJ
bam-14272	25	7	myocyte	myocyte	NOUN
bam-14272	25	8	injury	injury	NOUN
bam-14272	25	9	;	;	PUNCT
bam-14272	25	10	left	leave	VERB
bam-14272	25	11	ventricular	ventricular	ADJ
bam-14272	25	12	diastolic	diastolic	ADJ
bam-14272	25	13	function	function	NOUN
bam-14272	25	14	;	;	PUNCT
bam-14272	25	15	hf	hf	X
bam-14272	25	16	-	-	PUNCT
bam-14272	25	17	pef	pef	NOUN
bam-14272	25	18	;	;	PUNCT
bam-14272	26	1	pci	pci	ADJ
bam-14272	26	2	.	.	PUNCT
bam-14272	26	3	heart	heart	NOUN
bam-14272	26	4	failure	failure	NOUN
bam-14272	26	5	with	with	ADP
bam-14272	26	6	preserved	preserve	VERB
bam-14272	26	7	ejection	ejection	NOUN
bam-14272	26	8	fraction	fraction	NOUN
bam-14272	26	9	(	(	PUNCT
bam-14272	26	10	hf	hf	NOUN
bam-14272	26	11	-	-	PUNCT
bam-14272	26	12	pef	pef	NOUN
bam-14272	26	13	)	)	PUNCT
bam-14272	26	14	is	be	AUX
bam-14272	26	15	a	a	DET
bam-14272	26	16	common	common	ADJ
bam-14272	26	17	cardiac	cardiac	ADJ
bam-14272	26	18	condition	condition	NOUN
bam-14272	26	19	that	that	PRON
bam-14272	26	20	follows	follow	VERB
bam-14272	26	21	percutaneous	percutaneous	ADJ
bam-14272	26	22	coronary	coronary	ADJ
bam-14272	26	23	intervention	intervention	NOUN
bam-14272	26	24	(	(	PUNCT
bam-14272	26	25	pci	pci	ADJ
bam-14272	26	26	)	)	PUNCT
bam-14272	26	27	,	,	PUNCT
bam-14272	26	28	characterised	characterise	VERB
bam-14272	26	29	by	by	ADP
bam-14272	26	30	a	a	DET
bam-14272	26	31	normal	normal	ADJ
bam-14272	26	32	or	or	CCONJ
bam-14272	26	33	near	near	ADV
bam-14272	26	34	-	-	PUNCT
bam-14272	26	35	normal	normal	ADJ
bam-14272	26	36	left	leave	VERB
bam-14272	26	37	ventricular	ventricular	ADJ
bam-14272	26	38	ejection	ejection	NOUN
bam-14272	26	39	fraction	fraction	NOUN
bam-14272	26	40	(	(	PUNCT
bam-14272	26	41	lvef	lvef	NOUN
bam-14272	26	42	)	)	PUNCT
bam-14272	26	43	and	and	CCONJ
bam-14272	26	44	preserved	preserve	VERB
bam-14272	26	45	left	leave	VERB
bam-14272	26	46	ventricular	ventricular	ADJ
bam-14272	26	47	systolic	systolic	ADJ
bam-14272	26	48	function	function	NOUN
bam-14272	26	49	,	,	PUNCT
bam-14272	26	50	but	but	CCONJ
bam-14272	26	51	impaired	impaired	ADJ
bam-14272	26	52	diastolic	diastolic	NOUN
bam-14272	26	53	function	function	NOUN
bam-14272	26	54	.	.	PUNCT
bam-14272	27	1	clinical	clinical	ADJ
bam-14272	27	2	manifestations	manifestation	NOUN
bam-14272	27	3	include	include	VERB
bam-14272	27	4	dyspnea	dyspnea	NOUN
bam-14272	27	5	,	,	PUNCT
bam-14272	27	6	respiratory	respiratory	ADJ
bam-14272	27	7	distress	distress	NOUN
bam-14272	27	8	,	,	PUNCT
bam-14272	27	9	lower	low	ADJ
bam-14272	27	10	extremity	extremity	NOUN
bam-14272	27	11	edema	edema	NOUN
bam-14272	27	12	,	,	PUNCT
bam-14272	27	13	and	and	CCONJ
bam-14272	27	14	fatigue.1	fatigue.1	VERB
bam-14272	27	15	-	-	SYM
bam-14272	27	16	2	2	NUM
bam-14272	27	17	the	the	DET
bam-14272	27	18	occurrence	occurrence	NOUN
bam-14272	27	19	of	of	ADP
bam-14272	27	20	hf	hf	NOUN
bam-14272	27	21	-	-	PUNCT
bam-14272	27	22	pef	pef	NOUN
bam-14272	27	23	significantly	significantly	ADV
bam-14272	27	24	increases	increase	VERB
bam-14272	27	25	the	the	DET
bam-14272	27	26	incidence	incidence	NOUN
bam-14272	27	27	of	of	ADP
bam-14272	27	28	major	major	ADJ
bam-14272	27	29	adverse	adverse	ADJ
bam-14272	27	30	cardiovascular	cardiovascular	ADJ
bam-14272	27	31	events	event	NOUN
bam-14272	27	32	(	(	PUNCT
bam-14272	27	33	mace	mace	NOUN
bam-14272	27	34	)	)	PUNCT
bam-14272	27	35	,	,	PUNCT
bam-14272	27	36	posing	pose	VERB
bam-14272	27	37	substantial	substantial	ADJ
bam-14272	27	38	risks	risk	NOUN
bam-14272	27	39	to	to	PART
bam-14272	27	40	patient	patient	VERB
bam-14272	27	41	safety.3	safety.3	NOUN
bam-14272	27	42	while	while	SCONJ
bam-14272	27	43	routine	routine	ADJ
bam-14272	27	44	antiplatelet	antiplatelet	NOUN
bam-14272	27	45	therapy	therapy	NOUN
bam-14272	27	46	after	after	SCONJ
bam-14272	27	47	pci	pci	PROPN
bam-14272	27	48	can	can	AUX
bam-14272	27	49	improve	improve	VERB
bam-14272	27	50	cardiac	cardiac	ADJ
bam-14272	27	51	function	function	NOUN
bam-14272	27	52	and	and	CCONJ
bam-14272	27	53	alleviate	alleviate	VERB
bam-14272	27	54	symptoms	symptom	NOUN
bam-14272	27	55	,	,	PUNCT
bam-14272	27	56	its	its	PRON
bam-14272	27	57	overall	overall	ADJ
bam-14272	27	58	efficacy	efficacy	NOUN
bam-14272	27	59	remains	remain	VERB
bam-14272	27	60	suboptimal.4	suboptimal.4	NOUN
bam-14272	27	61	dapagliflozin	dapagliflozin	PROPN
bam-14272	27	62	,	,	PUNCT
bam-14272	27	63	a	a	DET
bam-14272	27	64	sodium	sodium	NOUN
bam-14272	27	65	-	-	PUNCT
bam-14272	27	66	glucose	glucose	NOUN
bam-14272	27	67	cotransportation	cotransportation	NOUN
bam-14272	27	68	system	system	NOUN
bam-14272	27	69	2	2	NUM
bam-14272	27	70	(	(	PUNCT
bam-14272	27	71	sglt2	sglt2	NOUN
bam-14272	27	72	)	)	PUNCT
bam-14272	27	73	inhibitor	inhibitor	NOUN
bam-14272	27	74	,	,	PUNCT
bam-14272	27	75	inhibits	inhibit	VERB
bam-14272	27	76	myocardial	myocardial	ADJ
bam-14272	27	77	calcium	calcium	NOUN
bam-14272	27	78	overload	overload	NOUN
bam-14272	27	79	and	and	CCONJ
bam-14272	27	80	sodium	sodium	NOUN
bam-14272	27	81	ion	ion	NOUN
bam-14272	27	82	influx	influx	NOUN
bam-14272	27	83	,	,	PUNCT
bam-14272	27	84	thereby	thereby	ADV
bam-14272	27	85	improving	improve	VERB
bam-14272	27	86	myocardial	myocardial	ADJ
bam-14272	27	87	fibrosis	fibrosis	NOUN
bam-14272	27	88	and	and	CCONJ
bam-14272	27	89	preventing	prevent	VERB
bam-14272	27	90	ventricular	ventricular	ADJ
bam-14272	27	91	hypertrophy.5	hypertrophy.5	PROPN
bam-14272	27	92	-	-	PUNCT
bam-14272	27	93	6	6	NUM
bam-14272	27	94	this	this	DET
bam-14272	27	95	study	study	NOUN
bam-14272	27	96	investigates	investigate	VERB
bam-14272	27	97	the	the	DET
bam-14272	27	98	effects	effect	NOUN
bam-14272	27	99	of	of	ADP
bam-14272	27	100	dapagliflozin	dapagliflozin	NOUN
bam-14272	27	101	on	on	ADP
bam-14272	27	102	cardiac	cardiac	ADJ
bam-14272	27	103	troponin	troponin	ADJ
bam-14272	27	104	,	,	PUNCT
bam-14272	27	105	serum	serum	NOUN
bam-14272	27	106	amyloid	amyloid	PROPN
bam-14272	27	107	a	a	DET
bam-14272	27	108	(	(	PUNCT
bam-14272	27	109	saa	saa	PROPN
bam-14272	27	110	)	)	PUNCT
bam-14272	27	111	,	,	PUNCT
bam-14272	27	112	and	and	CCONJ
bam-14272	27	113	left	leave	VERB
bam-14272	27	114	ventricular	ventricular	ADJ
bam-14272	27	115	end	end	NOUN
bam-14272	27	116	-	-	PUNCT
bam-14272	27	117	diastolic	diastolic	NOUN
bam-14272	27	118	volume	volume	NOUN
bam-14272	27	119	(	(	PUNCT
bam-14272	27	120	lvedv	lvedv	NOUN
bam-14272	27	121	)	)	PUNCT
bam-14272	27	122	in	in	ADP
bam-14272	27	123	post	post	ADJ
bam-14272	27	124	-	-	ADJ
bam-14272	27	125	picf	picf	ADJ
bam-14272	27	126	patients	patient	NOUN
bam-14272	27	127	.	.	PUNCT
bam-14272	28	1	materials	material	NOUN
bam-14272	28	2	and	and	CCONJ
bam-14272	28	3	methods	method	NOUN
bam-14272	28	4	general	general	ADJ
bam-14272	28	5	information	information	NOUN
bam-14272	28	6	this	this	DET
bam-14272	28	7	study	study	NOUN
bam-14272	28	8	enrolled	enrol	VERB
bam-14272	28	9	120	120	NUM
bam-14272	28	10	post	post	ADJ
bam-14272	28	11	-	-	ADJ
bam-14272	28	12	ppci	ppci	ADJ
bam-14272	28	13	hf	hf	ADJ
bam-14272	28	14	-	-	PUNCT
bam-14272	28	15	pef	pef	NOUN
bam-14272	28	16	patients	patient	NOUN
bam-14272	28	17	treated	treat	VERB
bam-14272	28	18	at	at	ADP
bam-14272	28	19	our	our	PRON
bam-14272	28	20	hospital	hospital	NOUN
bam-14272	28	21	from	from	ADP
bam-14272	28	22	may	may	PROPN
bam-14272	28	23	2021	2021	NUM
bam-14272	28	24	to	to	PART
bam-14272	28	25	may	may	PROPN
bam-14272	28	26	2024	2024	NUM
bam-14272	28	27	,	,	PUNCT
bam-14272	28	28	divided	divide	VERB
bam-14272	28	29	into	into	ADP
bam-14272	28	30	two	two	NUM
bam-14272	28	31	groups	group	NOUN
bam-14272	28	32	based	base	VERB
bam-14272	28	33	on	on	ADP
bam-14272	28	34	treatment	treatment	NOUN
bam-14272	28	35	methods	method	NOUN
bam-14272	28	36	:	:	PUNCT
bam-14272	28	37	the	the	DET
bam-14272	28	38	conventional	conventional	ADJ
bam-14272	28	39	group	group	NOUN
bam-14272	28	40	(	(	PUNCT
bam-14272	28	41	n=49	n=49	NUM
bam-14272	28	42	)	)	PUNCT
bam-14272	28	43	and	and	CCONJ
bam-14272	28	44	the	the	DET
bam-14272	28	45	daglirenet	daglirenet	ADJ
bam-14272	28	46	group	group	NOUN
bam-14272	28	47	(	(	PUNCT
bam-14272	28	48	n=71	n=71	NOUN
bam-14272	28	49	)	)	PUNCT
bam-14272	28	50	.	.	PUNCT
bam-14272	29	1	the	the	DET
bam-14272	29	2	daglirenet	daglirenet	PROPN
bam-14272	29	3	group	group	NOUN
bam-14272	29	4	included	include	VERB
bam-14272	29	5	38	38	NUM
bam-14272	29	6	males	male	NOUN
bam-14272	29	7	and	and	CCONJ
bam-14272	29	8	33	33	NUM
bam-14272	29	9	females	female	NOUN
bam-14272	29	10	,	,	PUNCT
bam-14272	29	11	with	with	ADP
bam-14272	29	12	an	an	DET
bam-14272	29	13	average	average	ADJ
bam-14272	29	14	age	age	NOUN
bam-14272	29	15	of	of	ADP
bam-14272	29	16	63.55±5.04	63.55±5.04	NUM
bam-14272	29	17	years	year	NOUN
bam-14272	29	18	.	.	PUNCT
bam-14272	30	1	nyha	nyha	NOUN
bam-14272	30	2	classification	classification	NOUN
bam-14272	30	3	showed	show	VERB
bam-14272	30	4	15	15	NUM
bam-14272	30	5	grade	grade	NOUN
bam-14272	30	6	ii	ii	NOUN
bam-14272	30	7	,	,	PUNCT
bam-14272	30	8	35	35	NUM
bam-14272	30	9	grade	grade	NOUN
bam-14272	30	10	iii	iii	NOUN
bam-14272	30	11	,	,	PUNCT
bam-14272	30	12	and	and	CCONJ
bam-14272	30	13	21	21	NUM
bam-14272	30	14	grade	grade	NOUN
bam-14272	30	15	iv	iv	NUM
bam-14272	30	16	patients	patient	NOUN
bam-14272	30	17	.	.	PUNCT
bam-14272	31	1	the	the	DET
bam-14272	31	2	number	number	NOUN
bam-14272	31	3	of	of	ADP
bam-14272	31	4	stents	stent	NOUN
bam-14272	31	5	placed	place	VERB
bam-14272	31	6	ranged	range	VERB
bam-14272	31	7	from	from	ADP
bam-14272	31	8	2	2	NUM
bam-14272	31	9	to	to	ADP
bam-14272	31	10	3	3	NUM
bam-14272	31	11	,	,	PUNCT
bam-14272	31	12	averaging	average	VERB
bam-14272	31	13	2.34±0.57	2.34±0.57	PROPN
bam-14272	31	14	.	.	PUNCT
bam-14272	32	1	the	the	DET
bam-14272	32	2	conventional	conventional	ADJ
bam-14272	32	3	group	group	NOUN
bam-14272	32	4	comprised	comprise	VERB
bam-14272	32	5	28	28	NUM
bam-14272	32	6	males	male	NOUN
bam-14272	32	7	and	and	CCONJ
bam-14272	32	8	21	21	NUM
bam-14272	32	9	females	female	NOUN
bam-14272	32	10	,	,	PUNCT
bam-14272	32	11	aged	age	VERB
bam-14272	32	12	53	53	NUM
bam-14272	32	13	-	-	SYM
bam-14272	32	14	73	73	NUM
bam-14272	32	15	years	year	NOUN
bam-14272	32	16	(	(	PUNCT
bam-14272	32	17	average	average	ADJ
bam-14272	32	18	63.27±5.14	63.27±5.14	NUM
bam-14272	32	19	)	)	PUNCT
bam-14272	32	20	,	,	PUNCT
bam-14272	32	21	with	with	ADP
bam-14272	32	22	nyha	nyha	NOUN
bam-14272	32	23	classifications	classification	NOUN
bam-14272	32	24	of	of	ADP
bam-14272	32	25	11	11	NUM
bam-14272	32	26	grade	grade	NOUN
bam-14272	32	27	ii	ii	NOUN
bam-14272	32	28	,	,	PUNCT
bam-14272	32	29	24	24	NUM
bam-14272	32	30	grade	grade	NOUN
bam-14272	32	31	iii	iii	NOUN
bam-14272	32	32	,	,	PUNCT
bam-14272	32	33	and	and	CCONJ
bam-14272	32	34	14	14	NUM
bam-14272	32	35	grade	grade	NOUN
bam-14272	32	36	iv	iv	NUM
bam-14272	32	37	patients	patient	NOUN
bam-14272	32	38	.	.	PUNCT
bam-14272	33	1	stent	stent	NOUN
bam-14272	33	2	placement	placement	NOUN
bam-14272	33	3	averaged	average	VERB
bam-14272	33	4	2.36±0.51	2.36±0.51	PROPN
bam-14272	33	5	,	,	PUNCT
bam-14272	33	6	ranging	range	VERB
bam-14272	33	7	from	from	ADP
bam-14272	33	8	1	1	NUM
bam-14272	33	9	to	to	ADP
bam-14272	33	10	3	3	NUM
bam-14272	33	11	.	.	PUNCT
bam-14272	34	1	both	both	DET
bam-14272	34	2	groups	group	NOUN
bam-14272	34	3	were	be	AUX
bam-14272	34	4	comparable	comparable	ADJ
bam-14272	34	5	(	(	PUNCT
bam-14272	34	6	p>0.05	p>0.05	PROPN
bam-14272	34	7	)	)	PUNCT
bam-14272	34	8	.	.	PUNCT
bam-14272	35	1	inclusion	inclusion	NOUN
bam-14272	35	2	criteria	criterion	NOUN
bam-14272	35	3	:	:	PUNCT
bam-14272	36	1	i	i	PRON
bam-14272	36	2	)	)	PUNCT
bam-14272	36	3	met	meet	VERB
bam-14272	36	4	the	the	DET
bam-14272	36	5	diagnostic	diagnostic	ADJ
bam-14272	36	6	criteria	criterion	NOUN
bam-14272	36	7	for	for	ADP
bam-14272	36	8	"	"	PUNCT
bam-14272	36	9	hf	hf	NOUN
bam-14272	36	10	-	-	PUNCT
bam-14272	36	11	pef	pef	NOUN
bam-14272	36	12	"	"	PUNCT
bam-14272	36	13	as	as	SCONJ
bam-14272	36	14	defined	define	VERB
bam-14272	36	15	in	in	ADP
bam-14272	36	16	the	the	DET
bam-14272	36	17	chinese	chinese	ADJ
bam-14272	36	18	expert	expert	NOUN
bam-14272	36	19	consensus	consensus	NOUN
bam-14272	36	20	on	on	ADP
bam-14272	36	21	diagnosis	diagnosis	NOUN
bam-14272	36	22	and	and	CCONJ
bam-14272	36	23	treatment	treatment	NOUN
bam-14272	36	24	of	of	ADP
bam-14272	36	25	heart	heart	NOUN
bam-14272	36	26	failure	failure	NOUN
bam-14272	36	27	with	with	ADP
bam-14272	36	28	preserved	preserve	VERB
bam-14272	36	29	ejection	ejection	NOUN
bam-14272	36	30	fraction;7	fraction;7	PROPN
bam-14272	36	31	ii	ii	PROPN
bam-14272	36	32	)	)	PUNCT
bam-14272	36	33	age	age	NOUN
bam-14272	36	34	≥18	≥18	NUM
bam-14272	36	35	years	year	NOUN
bam-14272	36	36	with	with	ADP
bam-14272	36	37	no	no	DET
bam-14272	36	38	gender	gender	NOUN
bam-14272	36	39	restrictions	restriction	NOUN
bam-14272	36	40	;	;	PUNCT
bam-14272	36	41	iii	iii	X
bam-14272	36	42	)	)	PUNCT
bam-14272	36	43	first	first	ADJ
bam-14272	36	44	-	-	PUNCT
bam-14272	36	45	time	time	NOUN
bam-14272	36	46	pci	pci	ADJ
bam-14272	36	47	patients	patient	NOUN
bam-14272	36	48	;	;	PUNCT
bam-14272	36	49	iv	iv	X
bam-14272	36	50	)	)	PUNCT
bam-14272	36	51	no	no	DET
bam-14272	36	52	abnormalities	abnormality	NOUN
bam-14272	36	53	in	in	ADP
bam-14272	36	54	major	major	ADJ
bam-14272	36	55	organ	organ	NOUN
bam-14272	36	56	functions	function	NOUN
bam-14272	36	57	such	such	ADJ
bam-14272	36	58	as	as	ADP
bam-14272	36	59	kidney	kidney	NOUN
bam-14272	36	60	or	or	CCONJ
bam-14272	36	61	liver	liver	NOUN
bam-14272	36	62	;	;	PUNCT
bam-14272	36	63	v	v	X
bam-14272	36	64	)	)	PUNCT
bam-14272	36	65	good	good	ADJ
bam-14272	36	66	cooperation	cooperation	NOUN
bam-14272	36	67	with	with	ADP
bam-14272	36	68	auditory	auditory	ADJ
bam-14272	36	69	,	,	PUNCT
bam-14272	36	70	visual	visual	ADJ
bam-14272	36	71	,	,	PUNCT
bam-14272	36	72	and	and	CCONJ
bam-14272	36	73	communication	communication	NOUN
bam-14272	36	74	abilities	ability	NOUN
bam-14272	36	75	.	.	PUNCT
bam-14272	37	1	exclusion	exclusion	NOUN
bam-14272	37	2	criteria	criterion	NOUN
bam-14272	37	3	:	:	PUNCT
bam-14272	38	1	i	i	X
bam-14272	38	2	)	)	PUNCT
bam-14272	38	3	patients	patient	NOUN
bam-14272	38	4	with	with	ADP
bam-14272	38	5	heart	heart	NOUN
bam-14272	38	6	failure	failure	NOUN
bam-14272	38	7	caused	cause	VERB
bam-14272	38	8	by	by	ADP
bam-14272	38	9	ventricular	ventricular	ADJ
bam-14272	38	10	aneurysm	aneurysm	NOUN
bam-14272	38	11	formation	formation	NOUN
bam-14272	38	12	or	or	CCONJ
bam-14272	38	13	papillary	papillary	ADJ
bam-14272	38	14	muscle	muscle	NOUN
bam-14272	38	15	dysfunction	dysfunction	NOUN
bam-14272	38	16	;	;	PUNCT
bam-14272	38	17	ii	ii	X
bam-14272	38	18	)	)	PUNCT
bam-14272	38	19	participants	participant	NOUN
bam-14272	38	20	in	in	ADP
bam-14272	38	21	other	other	ADJ
bam-14272	38	22	studies	study	NOUN
bam-14272	38	23	during	during	ADP
bam-14272	38	24	the	the	DET
bam-14272	38	25	same	same	ADJ
bam-14272	38	26	period	period	NOUN
bam-14272	38	27	;	;	PUNCT
bam-14272	38	28	iii	iii	X
bam-14272	38	29	)	)	PUNCT
bam-14272	38	30	patients	patient	NOUN
bam-14272	38	31	with	with	ADP
bam-14272	38	32	immune	immune	ADJ
bam-14272	38	33	deficiency	deficiency	NOUN
bam-14272	38	34	diseases	disease	NOUN
bam-14272	38	35	or	or	CCONJ
bam-14272	38	36	coagulation	coagulation	NOUN
bam-14272	38	37	disorders	disorder	NOUN
bam-14272	38	38	;	;	PUNCT
bam-14272	38	39	iv	iv	X
bam-14272	38	40	)	)	PUNCT
bam-14272	38	41	patients	patient	NOUN
bam-14272	38	42	with	with	ADP
bam-14272	38	43	concurrent	concurrent	ADJ
bam-14272	38	44	malignancies	malignancy	NOUN
bam-14272	38	45	;	;	PUNCT
bam-14272	38	46	v	v	X
bam-14272	38	47	)	)	PUNCT
bam-14272	38	48	patients	patient	NOUN
bam-14272	38	49	with	with	ADP
bam-14272	38	50	severe	severe	ADJ
bam-14272	38	51	infectious	infectious	ADJ
bam-14272	38	52	diseases	disease	NOUN
bam-14272	38	53	;	;	PUNCT
bam-14272	38	54	vi	vi	X
bam-14272	38	55	)	)	PUNCT
bam-14272	38	56	patients	patient	NOUN
bam-14272	38	57	with	with	ADP
bam-14272	38	58	hemodynamic	hemodynamic	ADJ
bam-14272	38	59	instability	instability	NOUN
bam-14272	38	60	.	.	PUNCT
bam-14272	39	1	the	the	DET
bam-14272	39	2	hospital	hospital	NOUN
bam-14272	39	3	's	's	PART
bam-14272	39	4	ethics	ethic	NOUN
bam-14272	39	5	committee	committee	NOUN
bam-14272	39	6	has	have	AUX
bam-14272	39	7	approved	approve	VERB
bam-14272	39	8	these	these	DET
bam-14272	39	9	criteria	criterion	NOUN
bam-14272	39	10	.	.	PUNCT
bam-14272	40	1	methodology	methodology	NOUN
bam-14272	40	2	this	this	PRON
bam-14272	40	3	was	be	AUX
bam-14272	40	4	a	a	DET
bam-14272	40	5	prospective	prospective	ADJ
bam-14272	40	6	observational	observational	ADJ
bam-14272	40	7	study	study	NOUN
bam-14272	40	8	.	.	PUNCT
bam-14272	41	1	both	both	DET
bam-14272	41	2	groups	group	NOUN
bam-14272	41	3	received	receive	VERB
bam-14272	41	4	basic	basic	ADJ
bam-14272	41	5	postoperative	postoperative	ADJ
bam-14272	41	6	care	care	NOUN
bam-14272	41	7	,	,	PUNCT
bam-14272	41	8	including	include	VERB
bam-14272	41	9	continuous	continuous	ADJ
bam-14272	41	10	low	low	ADJ
bam-14272	41	11	-	-	PUNCT
bam-14272	41	12	flow	flow	NOUN
bam-14272	41	13	oxygen	oxygen	NOUN
bam-14272	41	14	therapy	therapy	NOUN
bam-14272	41	15	,	,	PUNCT
bam-14272	41	16	electrocardiographic	electrocardiographic	ADJ
bam-14272	41	17	monitoring	monitoring	NOUN
bam-14272	41	18	,	,	PUNCT
bam-14272	41	19	and	and	CCONJ
bam-14272	41	20	bed	bed	NOUN
bam-14272	41	21	rest	rest	NOUN
bam-14272	41	22	after	after	ADP
bam-14272	41	23	pci	pci	ADJ
bam-14272	41	24	,	,	PUNCT
bam-14272	41	25	tailored	tailor	VERB
bam-14272	41	26	to	to	ADP
bam-14272	41	27	individual	individual	ADJ
bam-14272	41	28	patient	patient	ADJ
bam-14272	41	29	conditions	condition	NOUN
bam-14272	41	30	.	.	PUNCT
bam-14272	42	1	the	the	DET
bam-14272	42	2	conventional	conventional	ADJ
bam-14272	42	3	group	group	NOUN
bam-14272	42	4	continued	continue	VERB
bam-14272	42	5	standard	standard	ADJ
bam-14272	42	6	antiplatelet	antiplatelet	NOUN
bam-14272	42	7	therapy	therapy	NOUN
bam-14272	42	8	:	:	PUNCT
bam-14272	42	9	aspirin	aspirin	NOUN
bam-14272	42	10	enteric	enteric	NOUN
bam-14272	42	11	-	-	PUNCT
bam-14272	42	12	coated	coat	VERB
bam-14272	42	13	tablets	tablet	NOUN
bam-14272	42	14	(	(	PUNCT
bam-14272	42	15	100	100	NUM
bam-14272	42	16	mg	mg	ADV
bam-14272	42	17	orally	orally	ADV
bam-14272	42	18	,	,	PUNCT
bam-14272	42	19	once	once	ADV
bam-14272	42	20	daily	daily	ADV
bam-14272	42	21	)	)	PUNCT
bam-14272	42	22	,	,	PUNCT
bam-14272	42	23	clopidogrel	clopidogrel	NOUN
bam-14272	42	24	(	(	PUNCT
bam-14272	42	25	75	75	NUM
bam-14272	42	26	mg	mg	NOUN
bam-14272	42	27	orally	orally	ADV
bam-14272	42	28	,	,	PUNCT
bam-14272	42	29	once	once	ADV
bam-14272	42	30	daily	daily	ADV
bam-14272	42	31	)	)	PUNCT
bam-14272	42	32	or	or	CCONJ
bam-14272	42	33	ticagrelor	ticagrelor	NOUN
bam-14272	42	34	(	(	PUNCT
bam-14272	42	35	75	75	NUM
bam-14272	42	36	mg	mg	NOUN
bam-14272	42	37	twice	twice	ADV
bam-14272	42	38	daily	daily	ADV
bam-14272	42	39	)	)	PUNCT
bam-14272	42	40	,	,	PUNCT
bam-14272	42	41	along	along	ADP
bam-14272	42	42	with	with	ADP
bam-14272	42	43	metoprolol	metoprolol	PROPN
bam-14272	42	44	succinate	succinate	NOUN
bam-14272	42	45	extended	extend	VERB
bam-14272	42	46	-	-	PUNCT
bam-14272	42	47	release	release	NOUN
bam-14272	42	48	tablets	tablet	NOUN
bam-14272	42	49	(	(	PUNCT
bam-14272	42	50	11.875	11.875	NUM
bam-14272	42	51	-	-	SYM
bam-14272	42	52	47.5	47.5	NUM
bam-14272	42	53	mg	mg	NOUN
bam-14272	42	54	once	once	ADV
bam-14272	42	55	daily	daily	ADV
bam-14272	42	56	)	)	PUNCT
bam-14272	42	57	.	.	PUNCT
bam-14272	43	1	this	this	DET
bam-14272	43	2	regimen	regimen	NOUN
bam-14272	43	3	was	be	AUX
bam-14272	43	4	maintained	maintain	VERB
bam-14272	43	5	for	for	ADP
bam-14272	43	6	3	3	NUM
bam-14272	43	7	months	month	NOUN
bam-14272	43	8	.	.	PUNCT
bam-14272	44	1	the	the	DET
bam-14272	44	2	dapagliflozin	dapagliflozin	PROPN
bam-14272	44	3	group	group	PROPN
bam-14272	44	4	received	receive	VERB
bam-14272	44	5	an	an	DET
bam-14272	44	6	additional	additional	ADJ
bam-14272	44	7	3	3	NUM
bam-14272	44	8	-	-	PUNCT
bam-14272	44	9	month	month	NOUN
bam-14272	44	10	treatment	treatment	NOUN
bam-14272	44	11	with	with	ADP
bam-14272	44	12	dapagliflozin	dapagliflozin	PROPN
bam-14272	44	13	:	:	PUNCT
bam-14272	44	14	dapagliflozin	dapagliflozin	PROPN
bam-14272	44	15	tablets	tablet	NOUN
bam-14272	44	16	(	(	PUNCT
bam-14272	44	17	10	10	NUM
bam-14272	44	18	mg	mg	NOUN
bam-14272	44	19	orally	orally	ADV
bam-14272	44	20	,	,	PUNCT
bam-14272	44	21	once	once	ADV
bam-14272	44	22	daily	daily	ADV
bam-14272	44	23	)	)	PUNCT
bam-14272	44	24	.	.	PUNCT
bam-14272	45	1	observation	observation	NOUN
bam-14272	45	2	indicators	indicator	NOUN
bam-14272	45	3	serum	serum	VERB
bam-14272	45	4	cardiac	cardiac	ADJ
bam-14272	45	5	troponin	troponin	PROPN
bam-14272	45	6	i	i	PROPN
bam-14272	45	7	(	(	PUNCT
bam-14272	45	8	ctni	ctni	NOUN
bam-14272	45	9	)	)	PUNCT
bam-14272	45	10	and	and	CCONJ
bam-14272	45	11	saa	saa	PROPN
bam-14272	45	12	:	:	PUNCT
bam-14272	45	13	collect	collect	VERB
bam-14272	45	14	5ml	5ml	NOUN
bam-14272	45	15	of	of	ADP
bam-14272	45	16	fasting	fast	VERB
bam-14272	45	17	venous	venous	ADJ
bam-14272	45	18	blood	blood	NOUN
bam-14272	45	19	from	from	ADP
bam-14272	45	20	patients	patient	NOUN
bam-14272	45	21	before	before	ADP
bam-14272	45	22	and	and	CCONJ
bam-14272	45	23	after	after	ADP
bam-14272	45	24	treatment	treatment	NOUN
bam-14272	45	25	.	.	PUNCT
bam-14272	46	1	centrifuge	centrifuge	NOUN
bam-14272	46	2	at	at	ADP
bam-14272	46	3	3000r	3000r	NUM
bam-14272	46	4	/	/	SYM
bam-14272	46	5	min	min	NOUN
bam-14272	46	6	for	for	ADP
bam-14272	46	7	10	10	NUM
bam-14272	46	8	minutes	minute	NOUN
bam-14272	46	9	with	with	ADP
bam-14272	46	10	a	a	DET
bam-14272	46	11	10	10	NUM
bam-14272	46	12	cm	cm	NOUN
bam-14272	46	13	radius	radius	NOUN
bam-14272	46	14	.	.	PUNCT
bam-14272	47	1	the	the	DET
bam-14272	47	2	supernatant	supernatant	NOUN
bam-14272	47	3	was	be	AUX
bam-14272	47	4	separated	separate	VERB
bam-14272	47	5	and	and	CCONJ
bam-14272	47	6	stored	store	VERB
bam-14272	47	7	at-80	at-80	NOUN
bam-14272	47	8	°	°	ADP
bam-14272	47	9	℃	℃	PROPN
bam-14272	47	10	.	.	PUNCT
bam-14272	48	1	c	c	X
bam-14272	48	2	-	-	PUNCT
bam-14272	48	3	troponin	troponin	ADJ
bam-14272	48	4	t	t	PROPN
bam-14272	48	5	(	(	PUNCT
bam-14272	48	6	ctnt	ctnt	PROPN
bam-14272	48	7	)	)	PUNCT
bam-14272	48	8	was	be	AUX
bam-14272	48	9	detected	detect	VERB
bam-14272	48	10	using	use	VERB
bam-14272	48	11	rapid	rapid	ADJ
bam-14272	48	12	solid	solid	ADJ
bam-14272	48	13	-	-	PUNCT
bam-14272	48	14	phase	phase	NOUN
bam-14272	48	15	immunocapillary	immunocapillary	ADJ
bam-14272	48	16	chromatography	chromatography	NOUN
bam-14272	48	17	,	,	PUNCT
bam-14272	48	18	while	while	SCONJ
bam-14272	48	19	saa	saa	PROPN
bam-14272	48	20	was	be	AUX
bam-14272	48	21	analyzed	analyze	VERB
bam-14272	48	22	via	via	ADP
bam-14272	48	23	enzyme	enzyme	NOUN
bam-14272	48	24	-	-	PUNCT
bam-14272	48	25	linked	link	VERB
bam-14272	48	26	immunosorbent	immunosorbent	NOUN
bam-14272	48	27	assay	assay	PROPN
bam-14272	48	28	(	(	PUNCT
bam-14272	48	29	elisa	elisa	NOUN
bam-14272	48	30	)	)	PUNCT
bam-14272	48	31	.	.	PUNCT
bam-14272	49	1	(	(	PUNCT
bam-14272	49	2	2	2	X
bam-14272	49	3	)	)	PUNCT
bam-14272	49	4	left	leave	VERB
bam-14272	49	5	ventricular	ventricular	ADJ
bam-14272	49	6	function	function	NOUN
bam-14272	49	7	indicators	indicator	NOUN
bam-14272	49	8	:	:	PUNCT
bam-14272	49	9	using	use	VERB
bam-14272	49	10	a	a	DET
bam-14272	49	11	color	color	NOUN
bam-14272	49	12	doppler	doppler	NOUN
bam-14272	49	13	ultrasound	ultrasound	NOUN
bam-14272	49	14	system	system	NOUN
bam-14272	49	15	(	(	PUNCT
bam-14272	49	16	model	model	NOUN
bam-14272	49	17	:	:	PUNCT
bam-14272	49	18	acuson	acuson	NOUN
bam-14272	49	19	sc2000	sc2000	PROPN
bam-14272	49	20	;	;	PUNCT
bam-14272	49	21	manufacturer	manufacturer	NOUN
bam-14272	49	22	:	:	PUNCT
bam-14272	49	23	siemens	siemen	NOUN
bam-14272	49	24	)	)	PUNCT
bam-14272	49	25	,	,	PUNCT
bam-14272	49	26	measurements	measurement	NOUN
bam-14272	49	27	were	be	AUX
bam-14272	49	28	taken	take	VERB
bam-14272	49	29	to	to	PART
bam-14272	49	30	determine	determine	VERB
bam-14272	49	31	left	leave	VERB
bam-14272	49	32	ventricular	ventricular	ADJ
bam-14272	49	33	ejection	ejection	NOUN
bam-14272	49	34	fraction	fraction	NOUN
bam-14272	49	35	(	(	PUNCT
bam-14272	49	36	ef	ef	PROPN
bam-14272	49	37	)	)	PUNCT
bam-14272	49	38	and	and	CCONJ
bam-14272	49	39	the	the	DET
bam-14272	49	40	e	e	NOUN
bam-14272	49	41	/	/	SYM
bam-14272	49	42	e	e	NOUN
bam-14272	49	43	'	'	PART
bam-14272	49	44	ratio	ratio	NOUN
bam-14272	49	45	,	,	PUNCT
bam-14272	49	46	calculated	calculate	VERB
bam-14272	49	47	as	as	ADP
bam-14272	49	48	the	the	DET
bam-14272	49	49	ratio	ratio	NOUN
bam-14272	49	50	of	of	ADP
bam-14272	49	51	early	early	ADJ
bam-14272	49	52	diastolic	diastolic	ADJ
bam-14272	49	53	mitral	mitral	ADJ
bam-14272	49	54	blood	blood	NOUN
bam-14272	49	55	flow	flow	NOUN
bam-14272	49	56	peak	peak	NOUN
bam-14272	49	57	velocity	velocity	NOUN
bam-14272	49	58	to	to	ADP
bam-14272	49	59	mitral	mitral	ADJ
bam-14272	49	60	annulus	annulus	NOUN
bam-14272	49	61	motion	motion	NOUN
bam-14272	49	62	velocity	velocity	NOUN
bam-14272	49	63	.	.	PUNCT
bam-14272	50	1	total	total	ADJ
bam-14272	50	2	incidence	incidence	NOUN
bam-14272	50	3	of	of	ADP
bam-14272	50	4	major	major	ADJ
bam-14272	50	5	adverse	adverse	ADJ
bam-14272	50	6	cardiovascular	cardiovascular	ADJ
bam-14272	50	7	events	event	NOUN
bam-14272	50	8	(	(	PUNCT
bam-14272	50	9	mace	mace	NOUN
bam-14272	50	10	):	):	PUNCT
bam-14272	50	11	the	the	DET
bam-14272	50	12	total	total	ADJ
bam-14272	50	13	incidence	incidence	NOUN
bam-14272	50	14	of	of	ADP
bam-14272	50	15	mace	mace	NOUN
bam-14272	50	16	including	include	VERB
bam-14272	50	17	malignant	malignant	ADJ
bam-14272	50	18	arrhythmia	arrhythmia	NOUN
bam-14272	50	19	,	,	PUNCT
bam-14272	50	20	recurrent	recurrent	ADJ
bam-14272	50	21	angina	angina	NOUN
bam-14272	50	22	pectoris	pectoris	ADJ
bam-14272	50	23	,	,	PUNCT
bam-14272	50	24	recurrent	recurrent	ADJ
bam-14272	50	25	myocardial	myocardial	ADJ
bam-14272	50	26	infarction	infarction	NOUN
bam-14272	50	27	,	,	PUNCT
bam-14272	50	28	revascularization	revascularization	NOUN
bam-14272	50	29	,	,	PUNCT
bam-14272	50	30	and	and	CCONJ
bam-14272	50	31	cardiogenic	cardiogenic	ADJ
bam-14272	50	32	death	death	NOUN
bam-14272	50	33	was	be	AUX
bam-14272	50	34	calculated	calculate	VERB
bam-14272	50	35	.	.	PUNCT
bam-14272	51	1	statistical	statistical	ADJ
bam-14272	51	2	methods	method	NOUN
bam-14272	51	3	spss26.0	spss26.0	NOUN
bam-14272	51	4	software	software	NOUN
bam-14272	51	5	was	be	AUX
bam-14272	51	6	used	use	VERB
bam-14272	51	7	for	for	ADP
bam-14272	51	8	statistical	statistical	ADJ
bam-14272	51	9	analysis	analysis	NOUN
bam-14272	51	10	.	.	PUNCT
bam-14272	52	1	for	for	ADP
bam-14272	52	2	the	the	DET
bam-14272	52	3	measurement	measurement	NOUN
bam-14272	52	4	data	datum	NOUN
bam-14272	52	5	（	（	PUNCT
bam-14272	52	6	±s	±s	PROPN
bam-14272	52	7	）	）	PROPN
bam-14272	52	8	,	,	PUNCT
bam-14272	52	9	t	t	PROPN
bam-14272	52	10	-	-	PUNCT
bam-14272	52	11	test	test	NOUN
bam-14272	52	12	was	be	AUX
bam-14272	52	13	adopted	adopt	VERB
bam-14272	52	14	,	,	PUNCT
bam-14272	52	15	and	and	CCONJ
bam-14272	52	16	for	for	ADP
bam-14272	52	17	the	the	DET
bam-14272	52	18	counting	counting	NOUN
bam-14272	52	19	data	datum	NOUN
bam-14272	52	20	[	[	X
bam-14272	52	21	n/(%	n/(%	NOUN
bam-14272	52	22	)	)	PUNCT
bam-14272	52	23	]	]	PUNCT
bam-14272	52	24	,	,	PUNCT
bam-14272	52	25	χ2	χ2	PROPN
bam-14272	52	26	test	test	NOUN
bam-14272	52	27	was	be	AUX
bam-14272	52	28	adopted	adopt	VERB
bam-14272	52	29	.	.	PUNCT
bam-14272	53	1	p<0.05	p<0.05	NOUN
bam-14272	53	2	,	,	PUNCT
bam-14272	53	3	and	and	CCONJ
bam-14272	53	4	the	the	DET
bam-14272	53	5	comparison	comparison	NOUN
bam-14272	53	6	showed	show	VERB
bam-14272	53	7	differences	difference	NOUN
bam-14272	53	8	.	.	PUNCT
bam-14272	53	9	!	!	PUNCT
bam-14272	54	1	results	result	VERB
bam-14272	54	2	comparison	comparison	NOUN
bam-14272	54	3	of	of	ADP
bam-14272	54	4	serum	serum	NOUN
bam-14272	54	5	ctni	ctni	NOUN
bam-14272	54	6	and	and	CCONJ
bam-14272	54	7	saa	saa	PROPN
bam-14272	54	8	between	between	ADP
bam-14272	54	9	the	the	DET
bam-14272	54	10	two	two	NUM
bam-14272	54	11	groups	group	NOUN
bam-14272	54	12	before	before	ADP
bam-14272	54	13	treatment	treatment	NOUN
bam-14272	54	14	,	,	PUNCT
bam-14272	54	15	serum	serum	NOUN
bam-14272	54	16	ctni	ctni	PROPN
bam-14272	54	17	and	and	CCONJ
bam-14272	54	18	saa	saa	PROPN
bam-14272	54	19	levels	level	NOUN
bam-14272	54	20	in	in	ADP
bam-14272	54	21	dapagliflozin	dapagliflozin	PROPN
bam-14272	54	22	group	group	PROPN
bam-14272	54	23	and	and	CCONJ
bam-14272	54	24	conventional	conventional	ADJ
bam-14272	54	25	group	group	NOUN
bam-14272	54	26	were	be	AUX
bam-14272	54	27	compared	compare	VERB
bam-14272	54	28	(	(	PUNCT
bam-14272	54	29	p>0.05	p>0.05	NOUN
bam-14272	54	30	)	)	PUNCT
bam-14272	54	31	.	.	PUNCT
bam-14272	55	1	after	after	ADP
bam-14272	55	2	treatment	treatment	NOUN
bam-14272	55	3	,	,	PUNCT
bam-14272	55	4	serum	serum	NOUN
bam-14272	55	5	ctni	ctni	PROPN
bam-14272	55	6	and	and	CCONJ
bam-14272	55	7	saa	saa	PROPN
bam-14272	55	8	levels	level	NOUN
bam-14272	55	9	in	in	ADP
bam-14272	55	10	both	both	DET
bam-14272	55	11	groups	group	NOUN
bam-14272	55	12	decreased	decrease	VERB
bam-14272	55	13	compared	compare	VERB
bam-14272	55	14	with	with	ADP
bam-14272	55	15	that	that	PRON
bam-14272	55	16	before	before	ADP
bam-14272	55	17	treatment	treatment	NOUN
bam-14272	55	18	(	(	PUNCT
bam-14272	55	19	p<0.05	p<0.05	NOUN
bam-14272	55	20	)	)	PUNCT
bam-14272	55	21	,	,	PUNCT
bam-14272	55	22	and	and	CCONJ
bam-14272	55	23	serum	serum	NOUN
bam-14272	55	24	ctni	ctni	PROPN
bam-14272	55	25	and	and	CCONJ
bam-14272	55	26	saa	saa	PROPN
bam-14272	55	27	levels	level	NOUN
bam-14272	55	28	in	in	ADP
bam-14272	55	29	dapagliflozin	dapagliflozin	PROPN
bam-14272	55	30	group	group	PROPN
bam-14272	55	31	were	be	AUX
bam-14272	55	32	lower	low	ADJ
bam-14272	55	33	than	than	ADP
bam-14272	55	34	those	those	PRON
bam-14272	55	35	in	in	ADP
bam-14272	55	36	conventional	conventional	ADJ
bam-14272	55	37	group	group	NOUN
bam-14272	55	38	(	(	PUNCT
bam-14272	55	39	p<0.05	p<0.05	PROPN
bam-14272	55	40	)	)	PUNCT
bam-14272	55	41	,	,	PUNCT
bam-14272	55	42	as	as	SCONJ
bam-14272	55	43	shown	show	VERB
bam-14272	55	44	in	in	ADP
bam-14272	55	45	table	table	NOUN
bam-14272	55	46	1	1	NUM
bam-14272	55	47	.	.	PUNCT
bam-14272	55	48	comparison	comparison	NOUN
bam-14272	55	49	of	of	ADP
bam-14272	55	50	left	left	ADJ
bam-14272	55	51	ventricular	ventricular	ADJ
bam-14272	55	52	function	function	NOUN
bam-14272	55	53	indexes	index	NOUN
bam-14272	55	54	between	between	ADP
bam-14272	55	55	the	the	DET
bam-14272	55	56	two	two	NUM
bam-14272	55	57	groups	group	NOUN
bam-14272	55	58	before	before	ADP
bam-14272	55	59	treatment	treatment	NOUN
bam-14272	55	60	,	,	PUNCT
bam-14272	55	61	no	no	DET
bam-14272	55	62	ef	ef	NOUN
bam-14272	55	63	or	or	CCONJ
bam-14272	55	64	e	e	NOUN
bam-14272	55	65	/	/	SYM
bam-14272	55	66	e	e	NOUN
bam-14272	55	67	’	'	PUNCT
bam-14272	55	68	ratio	ratio	NOUN
bam-14272	55	69	differences	difference	NOUN
bam-14272	55	70	were	be	AUX
bam-14272	55	71	found	find	VERB
bam-14272	55	72	between	between	ADP
bam-14272	55	73	the	the	DET
bam-14272	55	74	dapagliflozin	dapagliflozin	PROPN
bam-14272	55	75	and	and	CCONJ
bam-14272	55	76	control	control	NOUN
bam-14272	55	77	groups	group	NOUN
bam-14272	55	78	(	(	PUNCT
bam-14272	55	79	p>0.05	p>0.05	PROPN
bam-14272	55	80	)	)	PUNCT
bam-14272	55	81	.	.	PUNCT
bam-14272	56	1	after	after	ADP
bam-14272	56	2	treatment	treatment	NOUN
bam-14272	56	3	,	,	PUNCT
bam-14272	56	4	ef	ef	PROPN
bam-14272	56	5	levels	level	NOUN
bam-14272	56	6	increased	increase	VERB
bam-14272	56	7	in	in	ADP
bam-14272	56	8	both	both	DET
bam-14272	56	9	groups	group	NOUN
bam-14272	56	10	compared	compare	VERB
bam-14272	56	11	to	to	PART
bam-14272	56	12	baseline	baseline	VERB
bam-14272	56	13	,	,	PUNCT
bam-14272	56	14	while	while	SCONJ
bam-14272	56	15	e	e	NOUN
bam-14272	56	16	/	/	SYM
bam-14272	56	17	e	e	NOUN
bam-14272	56	18	'	'	PUNCT
bam-14272	56	19	ratio	ratio	NOUN
bam-14272	56	20	decreased	decrease	VERB
bam-14272	56	21	in	in	ADP
bam-14272	56	22	daglilizumab	daglilizumab	ADJ
bam-14272	56	23	group	group	NOUN
bam-14272	56	24	(	(	PUNCT
bam-14272	56	25	p<0.05	p<0.05	NOUN
bam-14272	56	26	)	)	PUNCT
bam-14272	56	27	.	.	PUNCT
bam-14272	57	1	conversely	conversely	ADV
bam-14272	57	2	,	,	PUNCT
bam-14272	57	3	ef	ef	PROPN
bam-14272	57	4	level	level	NOUN
bam-14272	57	5	rose	rise	VERB
bam-14272	57	6	and	and	CCONJ
bam-14272	57	7	e	e	AUX
bam-14272	57	8	/	/	SYM
bam-14272	57	9	e	e	NOUN
bam-14272	57	10	'	'	PUNCT
bam-14272	57	11	ratio	ratio	NOUN
bam-14272	57	12	decreased	decrease	VERB
bam-14272	57	13	in	in	ADP
bam-14272	57	14	daglilizumab	daglilizumab	ADJ
bam-14272	57	15	group	group	NOUN
bam-14272	57	16	compared	compare	VERB
bam-14272	57	17	to	to	ADP
bam-14272	57	18	the	the	DET
bam-14272	57	19	conventional	conventional	ADJ
bam-14272	57	20	group	group	NOUN
bam-14272	57	21	(	(	PUNCT
bam-14272	57	22	p<0.05	p<0.05	PROPN
bam-14272	57	23	)	)	PUNCT
bam-14272	57	24	,	,	PUNCT
bam-14272	57	25	as	as	SCONJ
bam-14272	57	26	shown	show	VERB
bam-14272	57	27	in	in	ADP
bam-14272	57	28	table	table	NOUN
bam-14272	57	29	2	2	NUM
bam-14272	57	30	.	.	PUNCT
bam-14272	57	31	comparison	comparison	NOUN
bam-14272	57	32	of	of	ADP
bam-14272	57	33	total	total	ADJ
bam-14272	57	34	mace	mace	NOUN
bam-14272	57	35	incidence	incidence	NOUN
bam-14272	57	36	between	between	ADP
bam-14272	57	37	the	the	DET
bam-14272	57	38	two	two	NUM
bam-14272	57	39	groups	group	NOUN
bam-14272	57	40	the	the	DET
bam-14272	57	41	overall	overall	ADJ
bam-14272	57	42	incidence	incidence	NOUN
bam-14272	57	43	of	of	ADP
bam-14272	57	44	mace	mace	NOUN
bam-14272	57	45	in	in	ADP
bam-14272	57	46	the	the	DET
bam-14272	57	47	dapagliflozin	dapagliflozin	PROPN
bam-14272	57	48	group	group	NOUN
bam-14272	57	49	(	(	PUNCT
bam-14272	57	50	1.41	1.41	NUM
bam-14272	57	51	%	%	NOUN
bam-14272	57	52	)	)	PUNCT
bam-14272	57	53	was	be	AUX
bam-14272	57	54	lower	low	ADJ
bam-14272	57	55	than	than	ADP
bam-14272	57	56	that	that	PRON
bam-14272	57	57	in	in	ADP
bam-14272	57	58	the	the	DET
bam-14272	57	59	conventional	conventional	ADJ
bam-14272	57	60	group	group	NOUN
bam-14272	57	61	(	(	PUNCT
bam-14272	57	62	12.24	12.24	NUM
bam-14272	57	63	%	%	NOUN
bam-14272	57	64	)	)	PUNCT
bam-14272	57	65	(	(	PUNCT
bam-14272	57	66	p<0.05	p<0.05	NOUN
bam-14272	57	67	)	)	PUNCT
bam-14272	57	68	,	,	PUNCT
bam-14272	57	69	as	as	SCONJ
bam-14272	57	70	shown	show	VERB
bam-14272	57	71	in	in	ADP
bam-14272	57	72	table	table	NOUN
bam-14272	57	73	3	3	NUM
bam-14272	57	74	.	.	PUNCT
bam-14272	58	1	discussion	discussion	NOUN
bam-14272	58	2	and	and	CCONJ
bam-14272	58	3	conclusions	conclusion	NOUN
bam-14272	58	4	post	post	ADJ
bam-14272	58	5	-	-	ADJ
bam-14272	58	6	ppci	ppci	ADJ
bam-14272	58	7	myocardial	myocardial	ADJ
bam-14272	58	8	ischemia	ischemia	NOUN
bam-14272	58	9	-	-	PUNCT
bam-14272	58	10	reperfusion	reperfusion	NOUN
bam-14272	58	11	injury	injury	NOUN
bam-14272	58	12	can	can	AUX
bam-14272	58	13	lead	lead	VERB
bam-14272	58	14	to	to	ADP
bam-14272	58	15	myocardial	myocardial	ADJ
bam-14272	58	16	cell	cell	NOUN
bam-14272	58	17	death	death	NOUN
bam-14272	58	18	,	,	PUNCT
bam-14272	58	19	resulting	result	VERB
bam-14272	58	20	in	in	ADP
bam-14272	58	21	massive	massive	ADJ
bam-14272	58	22	release	release	NOUN
bam-14272	58	23	of	of	ADP
bam-14272	58	24	cardiac	cardiac	ADJ
bam-14272	58	25	troponin	troponin	ADJ
bam-14272	58	26	.	.	PUNCT
bam-14272	59	1	this	this	DET
bam-14272	59	2	triggers	trigger	NOUN
bam-14272	59	3	increased	increase	VERB
bam-14272	59	4	left	leave	VERB
bam-14272	59	5	ventricular	ventricular	ADJ
bam-14272	59	6	wall	wall	NOUN
bam-14272	59	7	tension	tension	NOUN
bam-14272	59	8	and	and	CCONJ
bam-14272	59	9	left	leave	VERB
bam-14272	59	10	atrial	atrial	ADJ
bam-14272	59	11	volume	volume	NOUN
bam-14272	59	12	,	,	PUNCT
bam-14272	59	13	significantly	significantly	ADV
bam-14272	59	14	increasing	increase	VERB
bam-14272	59	15	the	the	DET
bam-14272	59	16	risk	risk	NOUN
bam-14272	59	17	of	of	ADP
bam-14272	59	18	ventricular	ventricular	ADJ
bam-14272	59	19	remodeling	remodeling	NOUN
bam-14272	59	20	and	and	CCONJ
bam-14272	59	21	substantially	substantially	ADV
bam-14272	59	22	elevating	elevate	VERB
bam-14272	59	23	the	the	DET
bam-14272	59	24	incidence	incidence	NOUN
bam-14272	59	25	of	of	ADP
bam-14272	59	26	hf	hf	NOUN
bam-14272	59	27	-	-	PUNCT
bam-14272	59	28	pef.8,9	pef.8,9	NOUN
bam-14272	59	29	although	although	SCONJ
bam-14272	59	30	patients	patient	NOUN
bam-14272	59	31	with	with	ADP
bam-14272	59	32	hf	hf	NOUN
bam-14272	59	33	-	-	PUNCT
bam-14272	59	34	pef	pef	NOUN
bam-14272	59	35	maintain	maintain	VERB
bam-14272	59	36	relatively	relatively	ADV
bam-14272	59	37	normal	normal	ADJ
bam-14272	59	38	lvef	lvef	NOUN
bam-14272	59	39	,	,	PUNCT
bam-14272	59	40	their	their	PRON
bam-14272	59	41	prognosis	prognosis	NOUN
bam-14272	59	42	remains	remain	VERB
bam-14272	59	43	comparable	comparable	ADJ
bam-14272	59	44	to	to	ADP
bam-14272	59	45	those	those	PRON
bam-14272	59	46	with	with	ADP
bam-14272	59	47	hfref	hfref	NOUN
bam-14272	59	48	patients	patient	NOUN
bam-14272	59	49	.	.	PUNCT
bam-14272	60	1	this	this	DET
bam-14272	60	2	condition	condition	NOUN
bam-14272	60	3	severely	severely	ADV
bam-14272	60	4	compromises	compromise	VERB
bam-14272	60	5	quality	quality	NOUN
bam-14272	60	6	of	of	ADP
bam-14272	60	7	life	life	NOUN
bam-14272	60	8	and	and	CCONJ
bam-14272	60	9	imposes	impose	VERB
bam-14272	60	10	substantial	substantial	ADJ
bam-14272	60	11	burdens	burden	NOUN
bam-14272	60	12	on	on	ADP
bam-14272	60	13	both	both	DET
bam-14272	60	14	families	family	NOUN
bam-14272	60	15	and	and	CCONJ
bam-14272	60	16	society	society	NOUN
bam-14272	60	17	,	,	PUNCT
bam-14272	60	18	making	make	VERB
bam-14272	60	19	it	it	PRON
bam-14272	60	20	a	a	DET
bam-14272	60	21	clinically	clinically	ADV
bam-14272	60	22	significant	significant	ADJ
bam-14272	60	23	concern.10,11	concern.10,11	NOUN
bam-14272	60	24	therefore	therefore	ADV
bam-14272	60	25	,	,	PUNCT
bam-14272	60	26	developing	develop	VERB
bam-14272	60	27	effective	effective	ADJ
bam-14272	60	28	therapeutic	therapeutic	ADJ
bam-14272	60	29	strategies	strategy	NOUN
bam-14272	60	30	to	to	PART
bam-14272	60	31	improve	improve	VERB
bam-14272	60	32	cardiac	cardiac	ADJ
bam-14272	60	33	function	function	NOUN
bam-14272	60	34	in	in	ADP
bam-14272	60	35	post	post	ADJ
bam-14272	60	36	-	-	ADJ
bam-14272	60	37	ppci	ppci	ADJ
bam-14272	60	38	hf	hf	ADJ
bam-14272	60	39	-	-	PUNCT
bam-14272	60	40	pef	pef	NOUN
bam-14272	60	41	patients	patient	NOUN
bam-14272	60	42	has	have	AUX
bam-14272	60	43	become	become	VERB
bam-14272	60	44	a	a	DET
bam-14272	60	45	critical	critical	ADJ
bam-14272	60	46	focus	focus	NOUN
bam-14272	60	47	in	in	ADP
bam-14272	60	48	modern	modern	ADJ
bam-14272	60	49	clinical	clinical	ADJ
bam-14272	60	50	practice	practice	NOUN
bam-14272	60	51	.	.	PUNCT
bam-14272	61	1	this	this	DET
bam-14272	61	2	study	study	NOUN
bam-14272	61	3	demonstrated	demonstrate	VERB
bam-14272	61	4	that	that	SCONJ
bam-14272	61	5	the	the	DET
bam-14272	61	6	dapagliflozin	dapagliflozin	PROPN
bam-14272	61	7	group	group	PROPN
bam-14272	61	8	showed	show	VERB
bam-14272	61	9	lower	low	ADJ
bam-14272	61	10	serum	serum	NOUN
bam-14272	61	11	ctni	ctni	NOUN
bam-14272	61	12	and	and	CCONJ
bam-14272	61	13	saa	saa	PROPN
bam-14272	61	14	levels	level	NOUN
bam-14272	61	15	post	post	ADJ
bam-14272	61	16	-	-	NOUN
bam-14272	61	17	treatment	treatment	NOUN
bam-14272	61	18	compared	compare	VERB
bam-14272	61	19	to	to	ADP
bam-14272	61	20	the	the	DET
bam-14272	61	21	conventional	conventional	ADJ
bam-14272	61	22	group	group	NOUN
bam-14272	61	23	,	,	PUNCT
bam-14272	61	24	indicating	indicate	VERB
bam-14272	61	25	its	its	PRON
bam-14272	61	26	effectiveness	effectiveness	NOUN
bam-14272	61	27	in	in	ADP
bam-14272	61	28	suppressing	suppress	VERB
bam-14272	61	29	myocardial	myocardial	ADJ
bam-14272	61	30	protein	protein	NOUN
bam-14272	61	31	and	and	CCONJ
bam-14272	61	32	saa	saa	PROPN
bam-14272	61	33	release	release	NOUN
bam-14272	61	34	in	in	ADP
bam-14272	61	35	hf	hf	NOUN
bam-14272	61	36	-	-	PUNCT
bam-14272	61	37	pef	pef	NOUN
bam-14272	61	38	patients	patient	NOUN
bam-14272	61	39	after	after	ADP
bam-14272	61	40	pci	pci	ADJ
bam-14272	61	41	.	.	PUNCT
bam-14272	62	1	the	the	DET
bam-14272	62	2	reduction	reduction	NOUN
bam-14272	62	3	in	in	ADP
bam-14272	62	4	ctni	ctni	NOUN
bam-14272	62	5	and	and	CCONJ
bam-14272	62	6	saa	saa	PROPN
bam-14272	62	7	observed	observe	VERB
bam-14272	62	8	in	in	ADP
bam-14272	62	9	this	this	DET
bam-14272	62	10	study	study	NOUN
bam-14272	62	11	reflects	reflect	VERB
bam-14272	62	12	a	a	DET
bam-14272	62	13	direct	direct	ADJ
bam-14272	62	14	protective	protective	ADJ
bam-14272	62	15	effect	effect	NOUN
bam-14272	62	16	of	of	ADP
bam-14272	62	17	dapagliflozin	dapagliflozin	PROPN
bam-14272	62	18	on	on	ADP
bam-14272	62	19	cardiac	cardiac	ADJ
bam-14272	62	20	myocytes	myocyte	NOUN
bam-14272	62	21	,	,	PUNCT
bam-14272	62	22	suggesting	suggest	VERB
bam-14272	62	23	reduced	reduce	VERB
bam-14272	62	24	myocardial	myocardial	ADJ
bam-14272	62	25	injury	injury	NOUN
bam-14272	62	26	and	and	CCONJ
bam-14272	62	27	fibrosis	fibrosis	NOUN
bam-14272	62	28	,	,	PUNCT
bam-14272	62	29	which	which	PRON
bam-14272	62	30	is	be	AUX
bam-14272	62	31	central	central	ADJ
bam-14272	62	32	to	to	ADP
bam-14272	62	33	preserving	preserve	VERB
bam-14272	62	34	cardiac	cardiac	ADJ
bam-14272	62	35	muscle	muscle	NOUN
bam-14272	62	36	function	function	NOUN
bam-14272	62	37	.	.	PUNCT
bam-14272	63	1	furthermore	furthermore	ADV
bam-14272	63	2	,	,	PUNCT
bam-14272	63	3	the	the	DET
bam-14272	63	4	dapagliflozin	dapagliflozin	PROPN
bam-14272	63	5	group	group	PROPN
bam-14272	63	6	showed	show	VERB
bam-14272	63	7	increased	increase	VERB
bam-14272	63	8	lvef	lvef	NOUN
bam-14272	63	9	and	and	CCONJ
bam-14272	63	10	decreased	decrease	VERB
bam-14272	63	11	e	e	NOUN
bam-14272	63	12	/	/	SYM
bam-14272	63	13	e′	e′	NOUN
bam-14272	63	14	ratio	ratio	NOUN
bam-14272	63	15	(	(	PUNCT
bam-14272	63	16	p<0.05	p<0.05	PROPN
bam-14272	63	17	)	)	PUNCT
bam-14272	63	18	,	,	PUNCT
bam-14272	63	19	suggesting	suggest	VERB
bam-14272	63	20	its	its	PRON
bam-14272	63	21	efficacy	efficacy	NOUN
bam-14272	63	22	in	in	ADP
bam-14272	63	23	restoring	restore	VERB
bam-14272	63	24	left	leave	VERB
bam-14272	63	25	ventricular	ventricular	ADJ
bam-14272	63	26	function	function	NOUN
bam-14272	63	27	after	after	ADP
bam-14272	63	28	pci	pci	ADJ
bam-14272	63	29	.	.	PUNCT
bam-14272	64	1	these	these	DET
bam-14272	64	2	findings	finding	NOUN
bam-14272	64	3	bridge	bridge	VERB
bam-14272	64	4	basic	basic	ADJ
bam-14272	64	5	pathophysiological	pathophysiological	ADJ
bam-14272	64	6	mechanisms	mechanism	NOUN
bam-14272	64	7	,	,	PUNCT
bam-14272	64	8	such	such	ADJ
bam-14272	64	9	as	as	ADP
bam-14272	64	10	inhibition	inhibition	NOUN
bam-14272	64	11	of	of	ADP
bam-14272	64	12	myocardial	myocardial	ADJ
bam-14272	64	13	fibrosis	fibrosis	NOUN
bam-14272	64	14	and	and	CCONJ
bam-14272	64	15	improved	improve	VERB
bam-14272	64	16	diastolic	diastolic	ADJ
bam-14272	64	17	relaxation	relaxation	NOUN
bam-14272	64	18	,	,	PUNCT
bam-14272	64	19	with	with	ADP
bam-14272	64	20	meaningful	meaningful	ADJ
bam-14272	64	21	clinical	clinical	ADJ
bam-14272	64	22	outcomes	outcome	NOUN
bam-14272	64	23	,	,	PUNCT
bam-14272	64	24	including	include	VERB
bam-14272	64	25	improved	improve	VERB
bam-14272	64	26	ef	ef	NOUN
bam-14272	64	27	and	and	CCONJ
bam-14272	64	28	reduced	reduced	ADJ
bam-14272	64	29	mace	mace	NOUN
bam-14272	64	30	,	,	PUNCT
bam-14272	64	31	highlighting	highlight	VERB
bam-14272	64	32	the	the	DET
bam-14272	64	33	translational	translational	ADJ
bam-14272	64	34	impact	impact	NOUN
bam-14272	64	35	of	of	ADP
bam-14272	64	36	dapagliflozin	dapagliflozin	PROPN
bam-14272	64	37	.	.	PUNCT
bam-14272	65	1	the	the	DET
bam-14272	65	2	underlying	underlying	ADJ
bam-14272	65	3	mechanisms	mechanism	NOUN
bam-14272	65	4	may	may	AUX
bam-14272	65	5	involve	involve	VERB
bam-14272	65	6	multiple	multiple	ADJ
bam-14272	65	7	pathways	pathway	NOUN
bam-14272	65	8	.	.	PUNCT
bam-14272	66	1	dapagliflozin	dapagliflozin	PROPN
bam-14272	66	2	helps	help	VERB
bam-14272	66	3	control	control	VERB
bam-14272	66	4	blood	blood	NOUN
bam-14272	66	5	glucose	glucose	NOUN
bam-14272	66	6	levels	level	NOUN
bam-14272	66	7	while	while	SCONJ
bam-14272	66	8	exerting	exert	VERB
bam-14272	66	9	mild	mild	ADJ
bam-14272	66	10	diuretic	diuretic	ADJ
bam-14272	66	11	effects	effect	NOUN
bam-14272	66	12	and	and	CCONJ
bam-14272	66	13	enhancing	enhance	VERB
bam-14272	66	14	function	function	NOUN
bam-14272	66	15	of	of	ADP
bam-14272	66	16	vascular	vascular	ADJ
bam-14272	66	17	endothelium.12	endothelium.12	NOUN
bam-14272	66	18	its	its	PRON
bam-14272	66	19	benefits	benefit	NOUN
bam-14272	66	20	can	can	AUX
bam-14272	66	21	be	be	AUX
bam-14272	66	22	attributed	attribute	VERB
bam-14272	66	23	to	to	ADP
bam-14272	66	24	improved	improve	VERB
bam-14272	66	25	myocardial	myocardial	ADJ
bam-14272	66	26	microcirculation	microcirculation	NOUN
bam-14272	66	27	,	,	PUNCT
bam-14272	66	28	inhibition	inhibition	NOUN
bam-14272	66	29	of	of	ADP
bam-14272	66	30	ventricular	ventricular	ADJ
bam-14272	66	31	remodeling	remodeling	NOUN
bam-14272	66	32	,	,	PUNCT
bam-14272	66	33	and	and	CCONJ
bam-14272	66	34	prevention	prevention	NOUN
bam-14272	66	35	of	of	ADP
bam-14272	66	36	fibrosis.13,14	fibrosis.13,14	ADJ
bam-14272	66	37	potential	potential	ADJ
bam-14272	66	38	mechanisms	mechanism	NOUN
bam-14272	66	39	include	include	VERB
bam-14272	66	40	attenuation	attenuation	NOUN
bam-14272	66	41	of	of	ADP
bam-14272	66	42	oxidative	oxidative	ADJ
bam-14272	66	43	stress	stress	NOUN
bam-14272	66	44	,	,	PUNCT
bam-14272	66	45	improved	improve	VERB
bam-14272	66	46	coronary	coronary	ADJ
bam-14272	66	47	microcirculation	microcirculation	NOUN
bam-14272	66	48	,	,	PUNCT
bam-14272	66	49	inhibition	inhibition	NOUN
bam-14272	66	50	of	of	ADP
bam-14272	66	51	fibroblast	fibroblast	ADJ
bam-14272	66	52	activity	activity	NOUN
bam-14272	66	53	,	,	PUNCT
bam-14272	66	54	and	and	CCONJ
bam-14272	66	55	reduction	reduction	NOUN
bam-14272	66	56	of	of	ADP
bam-14272	66	57	extracellular	extracellular	ADJ
bam-14272	66	58	matrix	matrix	NOUN
bam-14272	66	59	deposition	deposition	NOUN
bam-14272	66	60	,	,	PUNCT
bam-14272	66	61	all	all	PRON
bam-14272	66	62	of	of	ADP
bam-14272	66	63	which	which	PRON
bam-14272	66	64	protect	protect	VERB
bam-14272	66	65	myocardial	myocardial	ADJ
bam-14272	66	66	tissue	tissue	NOUN
bam-14272	66	67	integrity15	integrity15	NOUN
bam-14272	66	68	.	.	PUNCT
bam-14272	67	1	similar	similar	ADJ
bam-14272	67	2	findings	finding	NOUN
bam-14272	67	3	from	from	ADP
bam-14272	67	4	previous	previous	ADJ
bam-14272	67	5	studies16	studies16	NOUN
bam-14272	67	6	confirm	confirm	VERB
bam-14272	67	7	that	that	SCONJ
bam-14272	67	8	dapagliflozin	dapagliflozin	PROPN
bam-14272	67	9	effectively	effectively	ADV
bam-14272	67	10	improves	improve	VERB
bam-14272	67	11	cardiac	cardiac	ADJ
bam-14272	67	12	function	function	NOUN
bam-14272	67	13	and	and	CCONJ
bam-14272	67	14	reduces	reduce	VERB
bam-14272	67	15	adverse	adverse	ADJ
bam-14272	67	16	events	event	NOUN
bam-14272	67	17	in	in	ADP
bam-14272	67	18	hf	hf	ADJ
bam-14272	67	19	-	-	PUNCT
bam-14272	67	20	pef	pef	NOUN
bam-14272	67	21	patients	patient	NOUN
bam-14272	67	22	,	,	PUNCT
bam-14272	67	23	consistent	consistent	ADJ
bam-14272	67	24	with	with	ADP
bam-14272	67	25	our	our	PRON
bam-14272	67	26	results	result	NOUN
bam-14272	67	27	.	.	PUNCT
bam-14272	68	1	given	give	VERB
bam-14272	68	2	emerging	emerge	VERB
bam-14272	68	3	evidence	evidence	NOUN
bam-14272	68	4	that	that	SCONJ
bam-14272	68	5	sglt2	sglt2	ADJ
bam-14272	68	6	inhibitors	inhibitor	NOUN
bam-14272	68	7	also	also	ADV
bam-14272	68	8	modulate	modulate	VERB
bam-14272	68	9	skeletal	skeletal	ADJ
bam-14272	68	10	muscle	muscle	NOUN
bam-14272	68	11	metabolism	metabolism	NOUN
bam-14272	68	12	and	and	CCONJ
bam-14272	68	13	exercise	exercise	VERB
bam-14272	68	14	tolerance	tolerance	NOUN
bam-14272	68	15	,	,	PUNCT
bam-14272	68	16	future	future	ADJ
bam-14272	68	17	studies	study	NOUN
bam-14272	68	18	should	should	AUX
bam-14272	68	19	explore	explore	VERB
bam-14272	68	20	parallel	parallel	ADJ
bam-14272	68	21	benefits	benefit	NOUN
bam-14272	68	22	in	in	ADP
bam-14272	68	23	both	both	CCONJ
bam-14272	68	24	cardiac	cardiac	ADJ
bam-14272	68	25	and	and	CCONJ
bam-14272	68	26	skeletal	skeletal	ADJ
bam-14272	68	27	muscle	muscle	NOUN
bam-14272	68	28	physiology	physiology	NOUN
bam-14272	68	29	.	.	PUNCT
bam-14272	69	1	this	this	PRON
bam-14272	69	2	will	will	AUX
bam-14272	69	3	be	be	AUX
bam-14272	69	4	particularly	particularly	ADV
bam-14272	69	5	relevant	relevant	ADJ
bam-14272	69	6	to	to	ADP
bam-14272	69	7	translational	translational	ADJ
bam-14272	69	8	myology	myology	NOUN
bam-14272	69	9	,	,	PUNCT
bam-14272	69	10	linking	link	VERB
bam-14272	69	11	cardiac	cardiac	ADJ
bam-14272	69	12	and	and	CCONJ
bam-14272	69	13	skeletal	skeletal	ADJ
bam-14272	69	14	muscle	muscle	NOUN
bam-14272	69	15	protection	protection	NOUN
bam-14272	69	16	within	within	ADP
bam-14272	69	17	the	the	DET
bam-14272	69	18	same	same	ADJ
bam-14272	69	19	therapeutic	therapeutic	ADJ
bam-14272	69	20	framework	framework	NOUN
bam-14272	69	21	.	.	PUNCT
bam-14272	70	1	clinically	clinically	ADV
bam-14272	70	2	,	,	PUNCT
bam-14272	70	3	dapagliflozin	dapagliflozin	PROPN
bam-14272	70	4	may	may	AUX
bam-14272	70	5	serve	serve	VERB
bam-14272	70	6	as	as	ADP
bam-14272	70	7	an	an	DET
bam-14272	70	8	adjunct	adjunct	ADJ
bam-14272	70	9	therapy	therapy	NOUN
bam-14272	70	10	post	post	ADJ
bam-14272	70	11	-	-	ADJ
bam-14272	70	12	pci	pci	ADJ
bam-14272	70	13	to	to	PART
bam-14272	70	14	reduce	reduce	VERB
bam-14272	70	15	hospital	hospital	NOUN
bam-14272	70	16	readmissions	readmission	NOUN
bam-14272	70	17	and	and	CCONJ
bam-14272	70	18	long	long	ADJ
bam-14272	70	19	-	-	PUNCT
bam-14272	70	20	term	term	NOUN
bam-14272	70	21	healthcare	healthcare	NOUN
bam-14272	70	22	burden	burden	NOUN
bam-14272	70	23	in	in	ADP
bam-14272	70	24	hf	hf	ADJ
bam-14272	70	25	-	-	PUNCT
bam-14272	70	26	pef	pef	NOUN
bam-14272	70	27	patients	patient	NOUN
bam-14272	70	28	.	.	PUNCT
bam-14272	71	1	these	these	DET
bam-14272	71	2	translational	translational	ADJ
bam-14272	71	3	implications	implication	NOUN
bam-14272	71	4	highlight	highlight	VERB
bam-14272	71	5	its	its	PRON
bam-14272	71	6	potential	potential	ADJ
bam-14272	71	7	role	role	NOUN
bam-14272	71	8	as	as	ADP
bam-14272	71	9	a	a	DET
bam-14272	71	10	muscle	muscle	NOUN
bam-14272	71	11	-	-	PUNCT
bam-14272	71	12	protective	protective	ADJ
bam-14272	71	13	therapeutic	therapeutic	ADJ
bam-14272	71	14	strategy	strategy	NOUN
bam-14272	71	15	in	in	ADP
bam-14272	71	16	cardiovascular	cardiovascular	ADJ
bam-14272	71	17	medicine	medicine	NOUN
bam-14272	71	18	.	.	PUNCT
bam-14272	72	1	this	this	DET
bam-14272	72	2	study	study	NOUN
bam-14272	72	3	has	have	VERB
bam-14272	72	4	a	a	DET
bam-14272	72	5	few	few	ADJ
bam-14272	72	6	shortcomings	shortcoming	NOUN
bam-14272	72	7	,	,	PUNCT
bam-14272	72	8	such	such	ADJ
bam-14272	72	9	as	as	ADP
bam-14272	72	10	its	its	PRON
bam-14272	72	11	single	single	ADJ
bam-14272	72	12	-	-	PUNCT
bam-14272	72	13	center	center	NOUN
bam-14272	72	14	design	design	NOUN
bam-14272	72	15	,	,	PUNCT
bam-14272	72	16	relatively	relatively	ADV
bam-14272	72	17	short	short	ADJ
bam-14272	72	18	duration	duration	NOUN
bam-14272	72	19	,	,	PUNCT
bam-14272	72	20	and	and	CCONJ
bam-14272	72	21	lack	lack	NOUN
bam-14272	72	22	of	of	ADP
bam-14272	72	23	additional	additional	ADJ
bam-14272	72	24	inflammatory	inflammatory	ADJ
bam-14272	72	25	or	or	CCONJ
bam-14272	72	26	imaging	imaging	NOUN
bam-14272	72	27	biomarkers	biomarker	NOUN
bam-14272	72	28	.	.	PUNCT
bam-14272	73	1	future	future	ADJ
bam-14272	73	2	multicenter	multicenter	NOUN
bam-14272	73	3	trials	trial	NOUN
bam-14272	73	4	with	with	ADP
bam-14272	73	5	longer	long	ADJ
bam-14272	73	6	follow	follow	VERB
bam-14272	73	7	-	-	PUNCT
bam-14272	73	8	up	up	NOUN
bam-14272	73	9	should	should	AUX
bam-14272	73	10	incorporate	incorporate	VERB
bam-14272	73	11	advanced	advanced	ADJ
bam-14272	73	12	imaging	imaging	NOUN
bam-14272	73	13	markers	marker	NOUN
bam-14272	73	14	and	and	CCONJ
bam-14272	73	15	skeletal	skeletal	ADJ
bam-14272	73	16	muscle	muscle	NOUN
bam-14272	73	17	function	function	NOUN
bam-14272	73	18	assessments	assessment	NOUN
bam-14272	73	19	to	to	PART
bam-14272	73	20	validate	validate	VERB
bam-14272	73	21	and	and	CCONJ
bam-14272	73	22	extend	extend	VERB
bam-14272	73	23	these	these	DET
bam-14272	73	24	findings	finding	NOUN
bam-14272	73	25	.	.	PUNCT
bam-14272	74	1	list	list	NOUN
bam-14272	74	2	of	of	ADP
bam-14272	74	3	abbreviations	abbreviation	NOUN
bam-14272	74	4	hf	hf	NOUN
bam-14272	74	5	-	-	PUNCT
bam-14272	74	6	pef	pef	NOUN
bam-14272	74	7	,	,	PUNCT
bam-14272	74	8	heart	heart	NOUN
bam-14272	74	9	failure	failure	NOUN
bam-14272	74	10	with	with	ADP
bam-14272	74	11	preserved	preserve	VERB
bam-14272	74	12	ejection	ejection	NOUN
bam-14272	74	13	fraction	fraction	NOUN
bam-14272	74	14	pci	pci	ADJ
bam-14272	74	15	,	,	PUNCT
bam-14272	74	16	percutaneous	percutaneous	ADJ
bam-14272	74	17	coronary	coronary	ADJ
bam-14272	74	18	intervention	intervention	NOUN
bam-14272	74	19	ctni	ctni	NOUN
bam-14272	74	20	,	,	PUNCT
bam-14272	74	21	cardiac	cardiac	ADJ
bam-14272	74	22	troponin	troponin	NOUN
bam-14272	74	23	i	i	PRON
bam-14272	74	24	ctnt	ctnt	VERB
bam-14272	74	25	,	,	PUNCT
bam-14272	74	26	cardiac	cardiac	ADJ
bam-14272	74	27	troponin	troponin	PROPN
bam-14272	74	28	t	t	PROPN
bam-14272	74	29	saa	saa	PROPN
bam-14272	74	30	,	,	PUNCT
bam-14272	74	31	serum	serum	PROPN
bam-14272	74	32	amyloid	amyloid	PROPN
bam-14272	74	33	a	a	DET
bam-14272	74	34	lvedv	lvedv	NOUN
bam-14272	74	35	,	,	PUNCT
bam-14272	74	36	left	leave	VERB
bam-14272	74	37	ventricular	ventricular	ADJ
bam-14272	74	38	end	end	NOUN
bam-14272	74	39	-	-	PUNCT
bam-14272	74	40	diastolic	diastolic	NOUN
bam-14272	74	41	volume	volume	NOUN
bam-14272	74	42	lvef	lvef	NOUN
bam-14272	74	43	(	(	PUNCT
bam-14272	74	44	ef	ef	PROPN
bam-14272	74	45	)	)	PUNCT
bam-14272	74	46	,	,	PUNCT
bam-14272	74	47	left	leave	VERB
bam-14272	74	48	ventricular	ventricular	ADJ
bam-14272	74	49	ejection	ejection	NOUN
bam-14272	74	50	fraction	fraction	NOUN
bam-14272	74	51	e	e	NOUN
bam-14272	74	52	/	/	SYM
bam-14272	74	53	e	e	NOUN
bam-14272	74	54	’	'	PUNCT
bam-14272	74	55	,	,	PUNCT
bam-14272	74	56	ratio	ratio	NOUN
bam-14272	74	57	of	of	ADP
bam-14272	74	58	early	early	ADJ
bam-14272	74	59	mitral	mitral	ADJ
bam-14272	74	60	inflow	inflow	NOUN
bam-14272	74	61	velocity	velocity	NOUN
bam-14272	74	62	to	to	PART
bam-14272	74	63	mitral	mitral	VERB
bam-14272	74	64	annular	annular	ADJ
bam-14272	74	65	early	early	ADJ
bam-14272	74	66	diastolic	diastolic	ADJ
bam-14272	74	67	velocity	velocity	NOUN
bam-14272	74	68	mace	mace	NOUN
bam-14272	74	69	,	,	PUNCT
bam-14272	74	70	major	major	ADJ
bam-14272	74	71	adverse	adverse	ADJ
bam-14272	74	72	cardiovascular	cardiovascular	ADJ
bam-14272	74	73	events	event	NOUN
bam-14272	74	74	nyha	nyha	PROPN
bam-14272	74	75	,	,	PUNCT
bam-14272	74	76	new	new	PROPN
bam-14272	74	77	york	york	PROPN
bam-14272	74	78	heart	heart	PROPN
bam-14272	74	79	association	association	PROPN
bam-14272	74	80	elisa	elisa	PROPN
bam-14272	74	81	,	,	PUNCT
bam-14272	74	82	enzyme	enzyme	NOUN
bam-14272	74	83	-	-	PUNCT
bam-14272	74	84	linked	link	VERB
bam-14272	74	85	immunosorbent	immunosorbent	NOUN
bam-14272	74	86	assay	assay	PROPN
bam-14272	74	87	sglt2	sglt2	PROPN
bam-14272	74	88	,	,	PUNCT
bam-14272	74	89	sodium	sodium	NOUN
bam-14272	74	90	–	–	PUNCT
bam-14272	74	91	glucose	glucose	NOUN
bam-14272	74	92	cotransporter	cotransporter	NOUN
bam-14272	74	93	2	2	NUM
bam-14272	74	94	hf	hf	NOUN
bam-14272	74	95	,	,	PUNCT
bam-14272	74	96	heart	heart	NOUN
bam-14272	74	97	failure	failure	NOUN
bam-14272	74	98	ppci	ppci	NOUN
bam-14272	74	99	,	,	PUNCT
bam-14272	74	100	post	post	ADJ
bam-14272	74	101	-	-	ADJ
bam-14272	74	102	percutaneous	percutaneous	ADJ
bam-14272	74	103	coronary	coronary	ADJ
bam-14272	74	104	intervention	intervention	NOUN
bam-14272	74	105	corresponding	correspond	VERB
bam-14272	74	106	author	author	PROPN
bam-14272	74	107	hu	hu	PROPN
bam-14272	75	1	min	min	PROPN
bam-14272	75	2	the	the	DET
bam-14272	75	3	second	second	ADJ
bam-14272	75	4	affiliated	affiliated	ADJ
bam-14272	75	5	hospital	hospital	NOUN
bam-14272	75	6	of	of	ADP
bam-14272	75	7	wannan	wannan	PROPN
bam-14272	75	8	medical	medical	ADJ
bam-14272	75	9	college，cardiothoracic	college，cardiothoracic	PROPN
bam-14272	75	10	and	and	CCONJ
bam-14272	75	11	vascular	vascular	ADJ
bam-14272	75	12	surgery，no	surgery，no	NOUN
bam-14272	75	13	.	.	PUNCT
bam-14272	76	1	10	10	NUM
bam-14272	76	2	kangfu	kangfu	ADJ
bam-14272	76	3	road	road	NOUN
bam-14272	76	4	,	,	PUNCT
bam-14272	76	5	jinghu	jinghu	NOUN
bam-14272	76	6	district	district	NOUN
bam-14272	76	7	,	,	PUNCT
bam-14272	76	8	wuhu	wuhu	PROPN
bam-14272	76	9	city	city	PROPN
bam-14272	76	10	241000	241000	NUM
bam-14272	76	11	,	,	PUNCT
bam-14272	76	12	china	china	PROPN
bam-14272	76	13	.	.	PUNCT
bam-14272	77	1	e	e	X
bam-14272	77	2	-	-	NOUN
bam-14272	77	3	mail	mail	NOUN
bam-14272	77	4	:	:	PUNCT
bam-14272	77	5	17384000611@163.com	17384000611@163.com	NUM
bam-14272	77	6	0009	0009	NUM
bam-14272	77	7	-	-	PUNCT
bam-14272	77	8	0002	0002	NUM
bam-14272	77	9	-	-	PUNCT
bam-14272	77	10	3524	3524	NUM
bam-14272	77	11	-	-	PUNCT
bam-14272	77	12	8711	8711	NUM
bam-14272	77	13	wang	wang	PROPN
bam-14272	77	14	lei	lei	X
bam-14272	77	15	15675536173@163.com	15675536173@163.com	NUM
bam-14272	77	16	0009	0009	NUM
bam-14272	77	17	-	-	PUNCT
bam-14272	77	18	0007	0007	NUM
bam-14272	77	19	-	-	PUNCT
bam-14272	77	20	3771	3771	NUM
bam-14272	77	21	-	-	SYM
bam-14272	77	22	8402	8402	NUM
bam-14272	77	23	chen	chen	PROPN
bam-14272	77	24	yue	yue	PROPN
bam-14272	77	25	17384000611@163.com	17384000611@163.com	NUM
bam-14272	77	26	0009	0009	NUM
bam-14272	77	27	-	-	PUNCT
bam-14272	77	28	0005	0005	NUM
bam-14272	77	29	-	-	PUNCT
bam-14272	77	30	8276	8276	NUM
bam-14272	77	31	-	-	SYM
bam-14272	77	32	0007	0007	NUM
bam-14272	77	33	mailto:17384000611@163.com	mailto:17384000611@163.com	NOUN
bam-14272	77	34	mailto:15675536173@163.com	mailto:15675536173@163.com	NOUN
bam-14272	77	35	mailto:17384000611@163.com	mailto:17384000611@163.com	PROPN
bam-14272	77	36	zhang	zhang	PROPN
bam-14272	77	37	gejun	gejun	PROPN
bam-14272	77	38	zgj1732544597@163.com	zgj1732544597@163.com	PROPN
bam-14272	77	39	0009	0009	NUM
bam-14272	77	40	-	-	PUNCT
bam-14272	77	41	0008	0008	NUM
bam-14272	77	42	-	-	PUNCT
bam-14272	77	43	9261	9261	NUM
bam-14272	77	44	-	-	PUNCT
bam-14272	77	45	9447	9447	NUM
bam-14272	77	46	wei	wei	PROPN
bam-14272	77	47	chao	chao	PROPN
bam-14272	77	48	zhichitianya021@163.com	zhichitianya021@163.com	PROPN
bam-14272	77	49	0009	0009	NUM
bam-14272	77	50	-	-	PUNCT
bam-14272	77	51	0000	0000	NUM
bam-14272	77	52	-	-	PUNCT
bam-14272	77	53	0593	0593	NUM
bam-14272	77	54	-	-	PUNCT
bam-14272	77	55	7466	7466	NUM
bam-14272	77	56	liu	liu	PROPN
bam-14272	77	57	qian	qian	PROPN
bam-14272	77	58	qianqian1956525@outlook.com	qianqian1956525@outlook.com	PROPN
bam-14272	77	59	0009	0009	NUM
bam-14272	77	60	-	-	PUNCT
bam-14272	77	61	0000	0000	NUM
bam-14272	77	62	-	-	PUNCT
bam-14272	77	63	0593	0593	NUM
bam-14272	77	64	-	-	PUNCT
bam-14272	77	65	7466	7466	NUM
bam-14272	77	66	conflict	conflict	NOUN
bam-14272	77	67	of	of	ADP
bam-14272	77	68	interest	interest	NOUN
bam-14272	77	69	the	the	DET
bam-14272	77	70	authors	author	NOUN
bam-14272	77	71	declare	declare	VERB
bam-14272	77	72	no	no	DET
bam-14272	77	73	potential	potential	ADJ
bam-14272	77	74	conflict	conflict	NOUN
bam-14272	77	75	of	of	ADP
bam-14272	77	76	interest	interest	NOUN
bam-14272	77	77	,	,	PUNCT
bam-14272	77	78	and	and	CCONJ
bam-14272	77	79	all	all	DET
bam-14272	77	80	authors	author	NOUN
bam-14272	77	81	confirm	confirm	VERB
bam-14272	77	82	accuracy	accuracy	NOUN
bam-14272	77	83	.	.	PUNCT
bam-14272	78	1	ethics	ethic	NOUN
bam-14272	78	2	approval	approval	VERB
bam-14272	78	3	the	the	DET
bam-14272	78	4	ethics	ethic	NOUN
bam-14272	78	5	committee	committee	PROPN
bam-14272	78	6	of	of	ADP
bam-14272	78	7	the	the	DET
bam-14272	78	8	second	second	ADJ
bam-14272	78	9	affiliated	affiliated	ADJ
bam-14272	78	10	hospital	hospital	NOUN
bam-14272	78	11	of	of	ADP
bam-14272	78	12	south	south	PROPN
bam-14272	78	13	anhui	anhui	PROPN
bam-14272	78	14	medical	medical	PROPN
bam-14272	78	15	colle	colle	PROPN
bam-14272	78	16	approved	approve	VERB
bam-14272	78	17	this	this	DET
bam-14272	78	18	study	study	NOUN
bam-14272	78	19	(	(	PUNCT
bam-14272	78	20	ethical	ethical	ADJ
bam-14272	78	21	approval	approval	NOUN
bam-14272	78	22	number	number	NOUN
bam-14272	78	23	:	:	PUNCT
bam-14272	78	24	wyefyls2025120	wyefyls2025120	PROPN
bam-14272	78	25	)	)	PUNCT
bam-14272	78	26	.	.	PUNCT
bam-14272	79	1	the	the	DET
bam-14272	79	2	study	study	NOUN
bam-14272	79	3	is	be	AUX
bam-14272	79	4	conformed	conform	VERB
bam-14272	79	5	with	with	ADP
bam-14272	79	6	the	the	DET
bam-14272	79	7	the	the	DET
bam-14272	79	8	second	second	ADJ
bam-14272	79	9	affiliated	affiliated	ADJ
bam-14272	79	10	hospital	hospital	NOUN
bam-14272	79	11	of	of	ADP
bam-14272	79	12	south	south	PROPN
bam-14272	79	13	anhui	anhui	PROPN
bam-14272	79	14	medical	medical	PROPN
bam-14272	79	15	college	college	PROPN
bam-14272	79	16	of	of	ADP
bam-14272	79	17	18	18	NUM
bam-14272	79	18	november	november	PROPN
bam-14272	79	19	2025	2025	NUM
bam-14272	79	20	,	,	PUNCT
bam-14272	79	21	concerning	concern	VERB
bam-14272	79	22	human	human	ADJ
bam-14272	79	23	and	and	CCONJ
bam-14272	79	24	animal	animal	NOUN
bam-14272	79	25	rights	right	NOUN
bam-14272	79	26	.	.	PUNCT
bam-14272	80	1	informed	inform	VERB
bam-14272	80	2	consent	consent	NOUN
bam-14272	80	3	all	all	DET
bam-14272	80	4	patients	patient	NOUN
bam-14272	80	5	participating	participate	VERB
bam-14272	80	6	in	in	ADP
bam-14272	80	7	this	this	DET
bam-14272	80	8	study	study	NOUN
bam-14272	80	9	signed	sign	VERB
bam-14272	80	10	a	a	DET
bam-14272	80	11	written	write	VERB
bam-14272	80	12	informed	inform	VERB
bam-14272	80	13	consent	consent	NOUN
bam-14272	80	14	form	form	NOUN
bam-14272	80	15	for	for	ADP
bam-14272	80	16	participating	participate	VERB
bam-14272	80	17	in	in	ADP
bam-14272	80	18	this	this	DET
bam-14272	80	19	study	study	NOUN
bam-14272	80	20	.	.	PUNCT
bam-14272	81	1	patient	patient	ADJ
bam-14272	81	2	consent	consent	NOUN
bam-14272	81	3	for	for	ADP
bam-14272	81	4	publication	publication	NOUN
bam-14272	81	5	written	write	VERB
bam-14272	81	6	informed	inform	VERB
bam-14272	81	7	consent	consent	NOUN
bam-14272	81	8	was	be	AUX
bam-14272	81	9	obtained	obtain	VERB
bam-14272	81	10	from	from	ADP
bam-14272	81	11	a	a	DET
bam-14272	81	12	legally	legally	ADV
bam-14272	81	13	authorized	authorize	VERB
bam-14272	81	14	representative(s	representative(s	NOUN
bam-14272	81	15	)	)	PUNCT
bam-14272	81	16	for	for	ADP
bam-14272	81	17	anonymized	anonymize	VERB
bam-14272	81	18	patient	patient	ADJ
bam-14272	81	19	information	information	NOUN
bam-14272	81	20	to	to	PART
bam-14272	81	21	be	be	AUX
bam-14272	81	22	published	publish	VERB
bam-14272	81	23	in	in	ADP
bam-14272	81	24	this	this	DET
bam-14272	81	25	article	article	NOUN
bam-14272	81	26	.	.	PUNCT
bam-14272	82	1	mailto:zgj1732544597@163.com	mailto:zgj1732544597@163.com	X
bam-14272	82	2	mailto:zhichitianya021@163.com	mailto:zhichitianya021@163.com	PROPN
bam-14272	82	3	mailto:qianqian1956525@outlook.com	mailto:qianqian1956525@outlook.com	PROPN
bam-14272	82	4	availability	availability	NOUN
bam-14272	82	5	of	of	ADP
bam-14272	82	6	data	datum	NOUN
bam-14272	82	7	and	and	CCONJ
bam-14272	82	8	materials	material	NOUN
bam-14272	82	9	all	all	DET
bam-14272	82	10	data	datum	NOUN
bam-14272	82	11	generated	generate	VERB
bam-14272	82	12	or	or	CCONJ
bam-14272	82	13	analyzed	analyze	VERB
bam-14272	82	14	during	during	ADP
bam-14272	82	15	this	this	DET
bam-14272	82	16	study	study	NOUN
bam-14272	82	17	are	be	AUX
bam-14272	82	18	included	include	VERB
bam-14272	82	19	in	in	ADP
bam-14272	82	20	this	this	DET
bam-14272	82	21	published	publish	VERB
bam-14272	82	22	article	article	NOUN
bam-14272	82	23	.	.	PUNCT
bam-14272	83	1	references	reference	NOUN
bam-14272	83	2	[	[	X
bam-14272	83	3	1	1	X
bam-14272	83	4	]	]	PUNCT
bam-14272	83	5	o’donovan	o’donovan	NOUN
bam-14272	83	6	an	an	PRON
bam-14272	83	7	,	,	PUNCT
bam-14272	83	8	herisson	herisson	NOUN
bam-14272	83	9	fm	fm	NOUN
bam-14272	83	10	,	,	PUNCT
bam-14272	83	11	fouhy	fouhy	PROPN
bam-14272	83	12	f	f	PROPN
bam-14272	83	13	,	,	PUNCT
bam-14272	83	14	et	et	PROPN
bam-14272	83	15	al	al	PROPN
bam-14272	83	16	.	.	PUNCT
bam-14272	84	1	gut	gut	VERB
bam-14272	84	2	microbiome	microbiome	NOUN
bam-14272	84	3	of	of	ADP
bam-14272	84	4	a	a	DET
bam-14272	84	5	porcine	porcine	NOUN
bam-14272	84	6	model	model	NOUN
bam-14272	84	7	of	of	ADP
bam-14272	84	8	metabolic	metabolic	NOUN
bam-14272	84	9	syndrome	syndrome	NOUN
bam-14272	84	10	and	and	CCONJ
bam-14272	84	11	hf	hf	NOUN
bam-14272	84	12	-	-	PUNCT
bam-14272	84	13	pef	pef	NOUN
bam-14272	84	14	.	.	PROPN
bam-14272	84	15	am	be	AUX
bam-14272	84	16	j	j	PROPN
bam-14272	84	17	physiology	physiology	NOUN
bam-14272	84	18	-	-	PUNCT
bam-14272	84	19	heart	heart	NOUN
bam-14272	84	20	circulat	circulat	NOUN
bam-14272	84	21	physiol	physiol	PROPN
bam-14272	84	22	2020;318	2020;318	NUM
bam-14272	84	23	:	:	PUNCT
bam-14272	84	24	h590	h590	PROPN
bam-14272	84	25	-	-	SYM
bam-14272	84	26	603	603	NUM
bam-14272	84	27	.	.	PUNCT
bam-14272	85	1	[	[	X
bam-14272	85	2	2	2	NUM
bam-14272	85	3	]	]	X
bam-14272	85	4	gao	gao	PROPN
bam-14272	85	5	m	m	PROPN
bam-14272	85	6	,	,	PUNCT
bam-14272	85	7	bai	bai	PROPN
bam-14272	85	8	w	w	PROPN
bam-14272	85	9	,	,	PUNCT
bam-14272	85	10	cheng	cheng	PROPN
bam-14272	85	11	s	s	PROPN
bam-14272	85	12	,	,	PUNCT
bam-14272	85	13	qi	qi	PROPN
bam-14272	85	14	x.	x.	NOUN
bam-14272	85	15	recent	recent	ADJ
bam-14272	85	16	evidence	evidence	NOUN
bam-14272	85	17	on	on	ADP
bam-14272	85	18	angiotensin	angiotensin	NOUN
bam-14272	85	19	receptor	receptor	NOUN
bam-14272	85	20	-	-	PUNCT
bam-14272	85	21	neprilsin	neprilsin	NOUN
bam-14272	85	22	inhibitor	inhibitor	NOUN
bam-14272	85	23	in	in	ADP
bam-14272	85	24	heart	heart	NOUN
bam-14272	85	25	failure	failure	NOUN
bam-14272	85	26	with	with	ADP
bam-14272	85	27	preserved	preserve	VERB
bam-14272	85	28	ejection	ejection	NOUN
bam-14272	85	29	fraction	fraction	NOUN
bam-14272	85	30	.	.	PUNCT
bam-14272	86	1	chinese	chinese	ADJ
bam-14272	86	2	general	general	ADJ
bam-14272	86	3	practice	practice	NOUN
bam-14272	86	4	2021;24:2967	2021;24:2967	NUM
bam-14272	86	5	.	.	PUNCT
bam-14272	87	1	[	[	X
bam-14272	87	2	3	3	X
bam-14272	87	3	]	]	X
bam-14272	87	4	yang	yang	PROPN
bam-14272	87	5	j	j	PROPN
bam-14272	87	6	,	,	PUNCT
bam-14272	87	7	lv	lv	PROPN
bam-14272	87	8	t	t	PROPN
bam-14272	87	9	,	,	PUNCT
bam-14272	87	10	zhou	zhou	PROPN
bam-14272	87	11	j	j	PROPN
bam-14272	87	12	,	,	PUNCT
bam-14272	87	13	et	et	PROPN
bam-14272	87	14	al	al	PROPN
bam-14272	87	15	.	.	PUNCT
bam-14272	88	1	the	the	DET
bam-14272	88	2	effect	effect	NOUN
bam-14272	88	3	of	of	ADP
bam-14272	88	4	ivabradine	ivabradine	NOUN
bam-14272	88	5	therapy	therapy	NOUN
bam-14272	88	6	on	on	ADP
bam-14272	88	7	dilated	dilate	VERB
bam-14272	88	8	cardiomyopathy	cardiomyopathy	ADJ
bam-14272	88	9	patients	patient	NOUN
bam-14272	88	10	with	with	ADP
bam-14272	88	11	congestive	congestive	ADJ
bam-14272	88	12	heart	heart	NOUN
bam-14272	88	13	failure	failure	NOUN
bam-14272	88	14	:	:	PUNCT
bam-14272	88	15	a	a	DET
bam-14272	88	16	systematic	systematic	ADJ
bam-14272	88	17	review	review	NOUN
bam-14272	88	18	and	and	CCONJ
bam-14272	88	19	meta	meta	ADJ
bam-14272	88	20	-	-	PUNCT
bam-14272	88	21	analysis	analysis	NOUN
bam-14272	88	22	.	.	PUNCT
bam-14272	89	1	front	front	PROPN
bam-14272	89	2	cardiovasc	cardiovasc	PROPN
bam-14272	89	3	med	me	VERB
bam-14272	89	4	2023;10:1149351	2023;10:1149351	PROPN
bam-14272	89	5	.	.	PUNCT
bam-14272	90	1	[	[	X
bam-14272	90	2	4	4	NUM
bam-14272	90	3	]	]	X
bam-14272	90	4	mentz	mentz	PROPN
bam-14272	90	5	rj	rj	PROPN
bam-14272	90	6	,	,	PUNCT
bam-14272	90	7	brunton	brunton	PROPN
bam-14272	90	8	sa	sa	PROPN
bam-14272	90	9	,	,	PUNCT
bam-14272	90	10	rangaswami	rangaswami	PROPN
bam-14272	90	11	j.	j.	PROPN
bam-14272	90	12	sodium	sodium	PROPN
bam-14272	90	13	-	-	PUNCT
bam-14272	90	14	glucose	glucose	NOUN
bam-14272	90	15	cotransporter-2	cotransporter-2	NUM
bam-14272	90	16	inhibition	inhibition	NOUN
bam-14272	90	17	for	for	ADP
bam-14272	90	18	heart	heart	NOUN
bam-14272	90	19	failure	failure	NOUN
bam-14272	90	20	with	with	ADP
bam-14272	90	21	preserved	preserve	VERB
bam-14272	90	22	ejection	ejection	NOUN
bam-14272	90	23	fraction	fraction	NOUN
bam-14272	90	24	and	and	CCONJ
bam-14272	90	25	chronic	chronic	ADJ
bam-14272	90	26	kidney	kidney	NOUN
bam-14272	90	27	disease	disease	NOUN
bam-14272	90	28	with	with	ADP
bam-14272	90	29	or	or	CCONJ
bam-14272	90	30	without	without	ADP
bam-14272	90	31	type	type	NOUN
bam-14272	90	32	2	2	NUM
bam-14272	90	33	diabetes	diabetes	NOUN
bam-14272	90	34	mellitus	mellitus	NOUN
bam-14272	90	35	:	:	PUNCT
bam-14272	90	36	a	a	DET
bam-14272	90	37	narrative	narrative	NOUN
bam-14272	90	38	review	review	NOUN
bam-14272	90	39	.	.	PUNCT
bam-14272	91	1	cardiovasc	cardiovasc	PROPN
bam-14272	91	2	diabetol	diabetol	VERB
bam-14272	91	3	2023;22:316	2023;22:316	NUM
bam-14272	91	4	.	.	PUNCT
bam-14272	92	1	[	[	X
bam-14272	92	2	5	5	NUM
bam-14272	92	3	]	]	SYM
bam-14272	92	4	li	li	PROPN
bam-14272	92	5	h	h	PROPN
bam-14272	92	6	,	,	PUNCT
bam-14272	92	7	qin	qin	PROPN
bam-14272	92	8	x	x	PROPN
bam-14272	92	9	,	,	PUNCT
bam-14272	92	10	zhang	zhang	PROPN
bam-14272	92	11	l	l	PROPN
bam-14272	92	12	,	,	PUNCT
bam-14272	92	13	et	et	PROPN
bam-14272	92	14	al	al	PROPN
bam-14272	92	15	.	.	PROPN
bam-14272	92	16	effect	effect	NOUN
bam-14272	92	17	of	of	ADP
bam-14272	92	18	sglt2	sglt2	ADJ
bam-14272	92	19	inhibitors	inhibitor	NOUN
bam-14272	92	20	on	on	ADP
bam-14272	92	21	inflammatory	inflammatory	ADJ
bam-14272	92	22	markers	marker	NOUN
bam-14272	92	23	and	and	CCONJ
bam-14272	92	24	oxygen	oxygen	NOUN
bam-14272	92	25	consumption	consumption	NOUN
bam-14272	92	26	in	in	ADP
bam-14272	92	27	non	non	ADJ
bam-14272	92	28	-	-	ADJ
bam-14272	92	29	diabetic	diabetic	ADJ
bam-14272	92	30	patients	patient	NOUN
bam-14272	92	31	with	with	ADP
bam-14272	92	32	stemi	stemi	PROPN
bam-14272	92	33	undergoing	undergo	VERB
bam-14272	92	34	primary	primary	ADJ
bam-14272	92	35	pci	pci	NOUN
bam-14272	92	36	:	:	PUNCT
bam-14272	92	37	a	a	DET
bam-14272	92	38	parallel	parallel	ADJ
bam-14272	92	39	design	design	NOUN
bam-14272	92	40	single	single	ADJ
bam-14272	92	41	blind	blind	ADJ
bam-14272	92	42	controlled	control	VERB
bam-14272	92	43	trial	trial	NOUN
bam-14272	92	44	.	.	PUNCT
bam-14272	93	1	heart	heart	NOUN
bam-14272	93	2	&	&	CCONJ
bam-14272	93	3	lung	lung	PROPN
bam-14272	93	4	2025;73:174	2025;73:174	PROPN
bam-14272	93	5	-	-	PUNCT
bam-14272	93	6	9	9	NUM
bam-14272	93	7	.	.	PUNCT
bam-14272	94	1	[	[	X
bam-14272	94	2	6	6	NUM
bam-14272	94	3	]	]	SYM
bam-14272	94	4	li	li	PROPN
bam-14272	94	5	s	s	PROPN
bam-14272	94	6	,	,	PUNCT
bam-14272	94	7	wang	wang	PROPN
bam-14272	94	8	l	l	PROPN
bam-14272	94	9	,	,	PUNCT
bam-14272	94	10	wang	wang	PROPN
bam-14272	94	11	p	p	PROPN
bam-14272	94	12	,	,	PUNCT
bam-14272	94	13	et	et	PROPN
bam-14272	94	14	al	al	PROPN
bam-14272	94	15	.	.	PROPN
bam-14272	94	16	dapagliflozin	dapagliflozin	PROPN
bam-14272	94	17	improves	improve	VERB
bam-14272	94	18	cardiac	cardiac	ADJ
bam-14272	94	19	function	function	NOUN
bam-14272	94	20	and	and	CCONJ
bam-14272	94	21	reduces	reduce	VERB
bam-14272	94	22	adverse	adverse	ADJ
bam-14272	94	23	events	event	NOUN
bam-14272	94	24	in	in	ADP
bam-14272	94	25	myocardial	myocardial	ADJ
bam-14272	94	26	infarction	infarction	NOUN
bam-14272	94	27	:	:	PUNCT
bam-14272	94	28	a	a	DET
bam-14272	94	29	meta	meta	ADJ
bam-14272	94	30	-	-	PUNCT
bam-14272	94	31	analysis	analysis	NOUN
bam-14272	94	32	in	in	ADP
bam-14272	94	33	diabetic	diabetic	ADJ
bam-14272	94	34	and	and	CCONJ
bam-14272	94	35	non	non	ADJ
bam-14272	94	36	-	-	ADJ
bam-14272	94	37	diabetic	diabetic	ADJ
bam-14272	94	38	populations	population	NOUN
bam-14272	94	39	.	.	PUNCT
bam-14272	95	1	front	front	ADJ
bam-14272	95	2	endocrinol	endocrinol	NOUN
bam-14272	95	3	2025;16:1594861	2025;16:1594861	NUM
bam-14272	95	4	.	.	PUNCT
bam-14272	96	1	[	[	X
bam-14272	96	2	7	7	X
bam-14272	96	3	]	]	X
bam-14272	96	4	editorial	editorial	NOUN
bam-14272	96	5	board	board	NOUN
bam-14272	96	6	of	of	ADP
bam-14272	96	7	chinese	chinese	PROPN
bam-14272	96	8	journal	journal	PROPN
bam-14272	96	9	of	of	ADP
bam-14272	96	10	cardiology	cardiology	NOUN
bam-14272	96	11	.	.	PUNCT
bam-14272	97	1	chinese	chinese	ADJ
bam-14272	97	2	guidelines	guideline	NOUN
bam-14272	97	3	for	for	ADP
bam-14272	97	4	the	the	DET
bam-14272	97	5	diagnosis	diagnosis	NOUN
bam-14272	97	6	and	and	CCONJ
bam-14272	97	7	treatment	treatment	NOUN
bam-14272	97	8	of	of	ADP
bam-14272	97	9	heart	heart	NOUN
bam-14272	97	10	failure	failure	NOUN
bam-14272	97	11	2024	2024	NUM
bam-14272	97	12	.	.	PUNCT
bam-14272	98	1	cardiol	cardiol	NOUN
bam-14272	98	2	discovery	discovery	PROPN
bam-14272	98	3	2025;5:1	2025;5:1	NUM
bam-14272	98	4	-	-	SYM
bam-14272	98	5	38	38	NUM
bam-14272	98	6	.	.	PUNCT
bam-14272	99	1	[	[	X
bam-14272	99	2	8	8	NUM
bam-14272	99	3	]	]	X
bam-14272	99	4	perticone	perticone	NOUN
bam-14272	99	5	m	m	PROPN
bam-14272	99	6	,	,	PUNCT
bam-14272	99	7	gigliotti	gigliotti	PROPN
bam-14272	99	8	s	s	PROPN
bam-14272	99	9	,	,	PUNCT
bam-14272	99	10	shehaj	shehaj	PROPN
bam-14272	99	11	e	e	PROPN
bam-14272	99	12	,	,	PUNCT
bam-14272	99	13	et	et	PROPN
bam-14272	99	14	al	al	PROPN
bam-14272	99	15	.	.	PUNCT
bam-14272	100	1	gut	gut	NOUN
bam-14272	100	2	permeability	permeability	NOUN
bam-14272	100	3	and	and	CCONJ
bam-14272	100	4	immune	immune	NOUN
bam-14272	100	5	-	-	PUNCT
bam-14272	100	6	mediated	mediate	VERB
bam-14272	100	7	inflammation	inflammation	NOUN
bam-14272	100	8	in	in	ADP
bam-14272	100	9	heart	heart	NOUN
bam-14272	100	10	failure	failure	NOUN
bam-14272	100	11	.	.	PUNCT
bam-14272	101	1	biomedicines	biomedicine	VERB
bam-14272	101	2	2024;12:1217	2024;12:1217	NUM
bam-14272	101	3	.	.	PUNCT
bam-14272	102	1	[	[	X
bam-14272	102	2	9	9	NUM
bam-14272	102	3	]	]	PUNCT
bam-14272	102	4	mohammed	mohammed	PROPN
bam-14272	102	5	ma	ma	PROPN
bam-14272	102	6	.	.	PROPN
bam-14272	102	7	nurses	nurses	PROPN
bam-14272	102	8	knowledge	knowledge	NOUN
bam-14272	102	9	regarding	regard	VERB
bam-14272	102	10	post	post	ADJ
bam-14272	102	11	cardiac	cardiac	ADJ
bam-14272	102	12	arrest	arrest	NOUN
bam-14272	102	13	care	care	NOUN
bam-14272	102	14	in	in	ADP
bam-14272	102	15	intensive	intensive	ADJ
bam-14272	102	16	care	care	NOUN
bam-14272	102	17	unit	unit	NOUN
bam-14272	102	18	of	of	ADP
bam-14272	102	19	omdurman	omdurman	PROPN
bam-14272	102	20	military	military	ADJ
bam-14272	102	21	hospital	hospital	NOUN
bam-14272	102	22	on	on	ADP
bam-14272	102	23	march	march	PROPN
bam-14272	102	24	to	to	ADP
bam-14272	102	25	september	september	PROPN
bam-14272	102	26	2017	2017	NUM
bam-14272	102	27	.	.	PUNCT
bam-14272	103	1	doctoral	doctoral	ADJ
bam-14272	103	2	dissertation	dissertation	NOUN
bam-14272	103	3	.	.	PUNCT
bam-14272	104	1	[	[	X
bam-14272	104	2	10	10	NUM
bam-14272	104	3	]	]	X
bam-14272	104	4	wang	wang	PROPN
bam-14272	104	5	f	f	PROPN
bam-14272	104	6	,	,	PUNCT
bam-14272	104	7	li	li	PROPN
bam-14272	104	8	c	c	PROPN
bam-14272	104	9	,	,	PUNCT
bam-14272	104	10	zhang	zhang	PROPN
bam-14272	104	11	x.	x.	PROPN
bam-14272	104	12	sacubitril	sacubitril	PROPN
bam-14272	104	13	/	/	SYM
bam-14272	104	14	valsartan	valsartan	PROPN
bam-14272	104	15	improves	improve	VERB
bam-14272	104	16	the	the	DET
bam-14272	104	17	prognosis	prognosis	NOUN
bam-14272	104	18	of	of	ADP
bam-14272	104	19	acute	acute	ADJ
bam-14272	104	20	myocardial	myocardial	ADJ
bam-14272	104	21	infarction	infarction	NOUN
bam-14272	104	22	:	:	PUNCT
bam-14272	104	23	a	a	DET
bam-14272	104	24	meta	meta	ADJ
bam-14272	104	25	-	-	PUNCT
bam-14272	104	26	analysis	analysis	NOUN
bam-14272	104	27	.	.	PUNCT
bam-14272	105	1	coron	coron	PROPN
bam-14272	105	2	artery	artery	NOUN
bam-14272	105	3	dis	dis	PROPN
bam-14272	105	4	2024;35:231	2024;35:231	PROPN
bam-14272	105	5	-	-	SYM
bam-14272	105	6	8	8	NUM
bam-14272	105	7	.	.	PUNCT
bam-14272	106	1	[	[	X
bam-14272	106	2	11	11	NUM
bam-14272	106	3	]	]	SYM
bam-14272	106	4	dangas	dangas	NOUN
bam-14272	106	5	g	g	NOUN
bam-14272	106	6	,	,	PUNCT
bam-14272	106	7	iakovou	iakovou	PROPN
bam-14272	106	8	i	i	PRON
bam-14272	106	9	,	,	PUNCT
bam-14272	106	10	nikolsky	nikolsky	ADJ
bam-14272	106	11	e	e	NOUN
bam-14272	106	12	,	,	PUNCT
bam-14272	106	13	et	et	PROPN
bam-14272	106	14	al	al	PROPN
bam-14272	106	15	.	.	PROPN
bam-14272	106	16	contrast	contrast	NOUN
bam-14272	106	17	-	-	PUNCT
bam-14272	106	18	induced	induce	VERB
bam-14272	106	19	nephropathy	nephropathy	NOUN
bam-14272	106	20	after	after	ADP
bam-14272	106	21	percutaneous	percutaneous	ADJ
bam-14272	106	22	coronary	coronary	ADJ
bam-14272	106	23	interventions	intervention	NOUN
bam-14272	106	24	in	in	ADP
bam-14272	106	25	relation	relation	NOUN
bam-14272	106	26	to	to	ADP
bam-14272	106	27	chronic	chronic	ADJ
bam-14272	106	28	kidney	kidney	NOUN
bam-14272	106	29	disease	disease	NOUN
bam-14272	106	30	and	and	CCONJ
bam-14272	106	31	hemodynamic	hemodynamic	ADJ
bam-14272	106	32	variables	variable	NOUN
bam-14272	106	33	.	.	PUNCT
bam-14272	107	1	am	be	AUX
bam-14272	107	2	j	j	PROPN
bam-14272	107	3	cardiol	cardiol	NOUN
bam-14272	107	4	2005;95:13	2005;95:13	NUM
bam-14272	107	5	-	-	SYM
bam-14272	107	6	9	9	NUM
bam-14272	107	7	.	.	PUNCT
bam-14272	108	1	[	[	X
bam-14272	108	2	12	12	NUM
bam-14272	108	3	]	]	X
bam-14272	108	4	lin	lin	PROPN
bam-14272	108	5	x	x	PROPN
bam-14272	108	6	,	,	PUNCT
bam-14272	108	7	fang	fang	PROPN
bam-14272	108	8	l.	l.	PROPN
bam-14272	108	9	pharmaceutical	pharmaceutical	PROPN
bam-14272	108	10	treatment	treatment	NOUN
bam-14272	108	11	for	for	ADP
bam-14272	108	12	heart	heart	NOUN
bam-14272	108	13	failure	failure	NOUN
bam-14272	108	14	.	.	PUNCT
bam-14272	109	1	adv	adv	PROPN
bam-14272	109	2	exp	exp	NOUN
bam-14272	109	3	med	med	ADJ
bam-14272	109	4	biol	biol	NOUN
bam-14272	109	5	2020;1177:269	2020;1177:269	PROPN
bam-14272	109	6	-	-	PUNCT
bam-14272	109	7	95	95	NUM
bam-14272	109	8	.	.	PUNCT
bam-14272	110	1	[	[	X
bam-14272	110	2	13	13	NUM
bam-14272	110	3	]	]	X
bam-14272	110	4	wang	wang	PROPN
bam-14272	110	5	h	h	PROPN
bam-14272	110	6	,	,	PUNCT
bam-14272	110	7	liu	liu	PROPN
bam-14272	110	8	c	c	PROPN
bam-14272	110	9	,	,	PUNCT
bam-14272	110	10	guo	guo	PROPN
bam-14272	110	11	x	x	X
bam-14272	110	12	,	,	PUNCT
bam-14272	110	13	et	et	PROPN
bam-14272	110	14	al	al	PROPN
bam-14272	110	15	.	.	PUNCT
bam-14272	110	16	effects	effect	NOUN
bam-14272	110	17	of	of	ADP
bam-14272	110	18	modified	modify	VERB
bam-14272	110	19	danggui	danggui	NOUN
bam-14272	110	20	sini	sini	PROPN
bam-14272	110	21	decoction	decoction	NOUN
bam-14272	110	22	as	as	ADP
bam-14272	110	23	adjuvant	adjuvant	ADJ
bam-14272	110	24	therapy	therapy	NOUN
bam-14272	110	25	for	for	ADP
bam-14272	110	26	angina	angina	PROPN
bam-14272	110	27	pectoris	pectoris	PROPN
bam-14272	110	28	in	in	ADP
bam-14272	110	29	coronary	coronary	ADJ
bam-14272	110	30	heart	heart	NOUN
bam-14272	110	31	disease	disease	NOUN
bam-14272	110	32	:	:	PUNCT
bam-14272	110	33	a	a	DET
bam-14272	110	34	systematic	systematic	ADJ
bam-14272	110	35	review	review	NOUN
bam-14272	110	36	and	and	CCONJ
bam-14272	110	37	meta	meta	ADJ
bam-14272	110	38	-	-	PUNCT
bam-14272	110	39	analysis	analysis	NOUN
bam-14272	110	40	based	base	VERB
bam-14272	110	41	on	on	ADP
bam-14272	110	42	randomised	randomised	ADJ
bam-14272	110	43	controlled	control	VERB
bam-14272	110	44	trials	trial	NOUN
bam-14272	110	45	.	.	PUNCT
bam-14272	111	1	front	front	ADJ
bam-14272	111	2	pharmacol	pharmacol	PROPN
bam-14272	111	3	2024;15:1375795	2024;15:1375795	NUM
bam-14272	111	4	.	.	PUNCT
bam-14272	112	1	[	[	X
bam-14272	112	2	14	14	NUM
bam-14272	112	3	]	]	X
bam-14272	112	4	zhao	zhao	PROPN
bam-14272	112	5	z	z	PROPN
bam-14272	112	6	,	,	PUNCT
bam-14272	112	7	zheng	zheng	PROPN
bam-14272	112	8	n	n	CCONJ
bam-14272	112	9	,	,	PUNCT
bam-14272	112	10	zhang	zhang	PROPN
bam-14272	112	11	t	t	PROPN
bam-14272	112	12	,	,	PUNCT
bam-14272	112	13	et	et	PROPN
bam-14272	112	14	al	al	PROPN
bam-14272	112	15	.	.	PUNCT
bam-14272	113	1	cardiorenal	cardiorenal	ADJ
bam-14272	113	2	protection	protection	NOUN
bam-14272	113	3	with	with	ADP
bam-14272	113	4	dapagliflozin	dapagliflozin	NOUN
bam-14272	113	5	in	in	ADP
bam-14272	113	6	patients	patient	NOUN
bam-14272	113	7	with	with	ADP
bam-14272	113	8	type	type	NOUN
bam-14272	113	9	2	2	NUM
bam-14272	113	10	diabetes	diabetes	NOUN
bam-14272	113	11	mellitus	mellitus	NOUN
bam-14272	113	12	and	and	CCONJ
bam-14272	113	13	chronic	chronic	ADJ
bam-14272	113	14	coronary	coronary	ADJ
bam-14272	113	15	syndrome	syndrome	NOUN
bam-14272	113	16	undergoing	undergo	VERB
bam-14272	113	17	percutaneous	percutaneous	ADJ
bam-14272	113	18	coronary	coronary	ADJ
bam-14272	113	19	intervention	intervention	NOUN
bam-14272	113	20	:	:	PUNCT
bam-14272	113	21	a	a	DET
bam-14272	113	22	registry	registry	NOUN
bam-14272	113	23	cross	cross	ADJ
bam-14272	113	24	-	-	ADJ
bam-14272	113	25	sectional	sectional	ADJ
bam-14272	113	26	study	study	NOUN
bam-14272	113	27	.	.	PUNCT
bam-14272	114	1	cardiovasc	cardiovasc	PROPN
bam-14272	114	2	diabetol	diabetol	VERB
bam-14272	114	3	2025;24:185	2025;24:185	PRON
bam-14272	114	4	.	.	PUNCT
bam-14272	115	1	[	[	X
bam-14272	115	2	15	15	NUM
bam-14272	115	3	]	]	X
bam-14272	115	4	scheen	scheen	PROPN
bam-14272	115	5	aj	aj	PROPN
bam-14272	115	6	.	.	PROPN
bam-14272	115	7	pharmacodynamics	pharmacodynamic	NOUN
bam-14272	115	8	,	,	PUNCT
bam-14272	115	9	efficacy	efficacy	NOUN
bam-14272	115	10	and	and	CCONJ
bam-14272	115	11	safety	safety	NOUN
bam-14272	115	12	of	of	ADP
bam-14272	115	13	sodium	sodium	NOUN
bam-14272	115	14	–	–	PUNCT
bam-14272	115	15	glucose	glucose	NOUN
bam-14272	115	16	co	co	ADJ
bam-14272	115	17	-	-	NOUN
bam-14272	115	18	transporter	transporter	ADJ
bam-14272	115	19	type	type	NOUN
bam-14272	115	20	2	2	NUM
bam-14272	115	21	(	(	PUNCT
bam-14272	115	22	sglt2	sglt2	NOUN
bam-14272	115	23	)	)	PUNCT
bam-14272	115	24	inhibitors	inhibitor	NOUN
bam-14272	115	25	for	for	ADP
bam-14272	115	26	the	the	DET
bam-14272	115	27	treatment	treatment	NOUN
bam-14272	115	28	of	of	ADP
bam-14272	115	29	type	type	NOUN
bam-14272	115	30	2	2	NUM
bam-14272	115	31	diabetes	diabetes	NOUN
bam-14272	115	32	mellitus	mellitus	NOUN
bam-14272	115	33	.	.	PUNCT
bam-14272	116	1	drugs	drug	NOUN
bam-14272	116	2	2015;75:33	2015;75:33	NUM
bam-14272	116	3	-	-	SYM
bam-14272	116	4	59	59	NUM
bam-14272	116	5	.	.	PUNCT
bam-14272	117	1	[	[	X
bam-14272	117	2	16	16	NUM
bam-14272	117	3	]	]	X
bam-14272	117	4	liu	liu	PROPN
bam-14272	117	5	c	c	PROPN
bam-14272	117	6	,	,	PUNCT
bam-14272	117	7	guo	guo	PROPN
bam-14272	117	8	x	x	PROPN
bam-14272	117	9	,	,	PUNCT
bam-14272	117	10	wang	wang	PROPN
bam-14272	117	11	h	h	PROPN
bam-14272	117	12	,	,	PUNCT
bam-14272	117	13	zhou	zhou	PROPN
bam-14272	117	14	y.	y.	PROPN
bam-14272	117	15	combination	combination	NOUN
bam-14272	117	16	of	of	ADP
bam-14272	117	17	qi	qi	NOUN
bam-14272	117	18	benefiting	benefit	VERB
bam-14272	117	19	and	and	CCONJ
bam-14272	117	20	blood	blood	NOUN
bam-14272	117	21	circulation	circulation	NOUN
bam-14272	117	22	promoting	promote	VERB
bam-14272	117	23	herbs	herb	NOUN
bam-14272	117	24	with	with	ADP
bam-14272	117	25	dapagliflozin	dapagliflozin	PROPN
bam-14272	117	26	in	in	ADP
bam-14272	117	27	the	the	DET
bam-14272	117	28	treatment	treatment	NOUN
bam-14272	117	29	of	of	ADP
bam-14272	117	30	type	type	NOUN
bam-14272	117	31	2	2	NUM
bam-14272	117	32	diabetes	diabetes	NOUN
bam-14272	117	33	mellitus	mellitus	NOUN
bam-14272	117	34	combined	combine	VERB
bam-14272	117	35	with	with	ADP
bam-14272	117	36	heart	heart	NOUN
bam-14272	117	37	failure	failure	NOUN
bam-14272	117	38	:	:	PUNCT
bam-14272	117	39	a	a	DET
bam-14272	117	40	systematic	systematic	ADJ
bam-14272	117	41	evaluation	evaluation	NOUN
bam-14272	117	42	and	and	CCONJ
bam-14272	117	43	meta	meta	ADJ
bam-14272	117	44	-	-	PUNCT
bam-14272	117	45	analysis	analysis	NOUN
bam-14272	117	46	based	base	VERB
bam-14272	117	47	on	on	ADP
bam-14272	117	48	a	a	DET
bam-14272	117	49	randomized	randomized	ADJ
bam-14272	117	50	controlled	control	VERB
bam-14272	117	51	trial	trial	NOUN
bam-14272	117	52	.	.	PUNCT
bam-14272	118	1	complement	complement	VERB
bam-14272	118	2	med	med	ADJ
bam-14272	118	3	res	re	NOUN
bam-14272	118	4	2024;31:551	2024;31:551	NUM
bam-14272	118	5	-	-	SYM
bam-14272	118	6	66	66	NUM
bam-14272	118	7	.	.	PUNCT